[
    {
        "sen": [
            "Thus, to better understand the emergence of the recent SARS‐CoV‐2 epidemic in Italy, we analyzed a larger and updated dataset of recently released data of the COVID‐2019 epidemic to improve more effective intervention strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset comprised (n = 141) complete genomes sequences from the current (2019‐2020) SARS‐CoV‐2 epidemic retrieved from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 353,
                "end": 359,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 361,
                "end": 384,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The complete dataset was assessed for the presence of phylogenetic signal by applying the likelihood mapping analysis implemented in the IQ‐TREE 1.6.8 software (http://www.iqtree.org)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better understand the establishment and transmission of the novel SARS‐CoV‐2 in Italy, the recent Italian genomes available on the ",
            "GISAID",
            " database were added to a dataset of 138 SARS‐CoV‐2 genomes from the global epidemic."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 715,
                "end": 721,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic inference robustness will be improved if other genomic sequences will be available to build an even more informative dataset despite the low heterogeneity of the sequenced strains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was designated as coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In late January 2020, WHO declared the outbreak a global pandemic with cases in more than 45 countries where the COVID-19 was spreading fast outside China, most significantly in South Korea, Italy, and Iran with over 2,924 deaths and 85,212 cases confirmed while 39,537 recovered on 29 February 2020, 06:05 AM (GMT)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is a positive-sense single-stranded RNA virus (+ssRNA)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic analysis indicates that COVID-19 likely originated from bats [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequence of COVID-19 RBD, together with its RBM that contacts receptor angiotensin-converting enzyme 2 (ACE2), was found similar to that of SARS coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In January 2020, a group of scientists demonstrated that ACE2 could act as the receptor for COVID-19 [17–21]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, COVID-19 differs from other previous strains in having several critical residues at the 2019-nCoV receptor-binding motif (particularly Gln493) which provide advantageous interactions with human ACE2 [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, there is no vaccine or approved treatment for humans, but Chinese traditional medicines, such as ShuFengJieDu capsules and Lianhuaqingwen capsules, could be possible treatments for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences of proposed epitopes were selected from the COVID-19 reference sequence using UCSF Chimera 1.10 and saved as a ",
            "PDB",
            " file."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1377,
                "end": 1380,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequence alignment of the COVID-19 envelope protein was done using BioEdit software which shows total conservation across four sequences which were retrieved from China and the USA (Figure 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Applying the advanced bioinformatics tools and databases, various peptide-based vaccines could be designed where the peptides act as ligands [61–63]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 is an RNA virus which tends to mutate more commonly than the DNA viruses [67]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These mutations lie on the surface of the protein, which makes COVID-19 more superior than other previous strains by inducing its sustainability leaving the immune system in a blind spot [68]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our present work, different peptides were proposed for designing a vaccine against COVID-19 (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the beginning, the whole genome of COVID-19 was analyzed by a comparative genomic approach to determine the potential antigenic target [69]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Artemis Comparison Tool (ACT) was used to analyze human coronavirus (HCoV-HKU1) reference sequence vs. Wuhan-Hu-1 COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "New genes (ORF8 and ORF6) were found inserted in COVID-19 which were absent in HCoV-HKU1 that might be acquired by the horizontal gene transmission [70]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple sequence alignment (MSA) was performed using ClustalW for the seven strains of coronavirus, which are COVID-19 (",
            "NC_04551",
            "), SARS-CoV (",
            "FJ211859",
            "), MESA-CoV (",
            "NC_019843",
            "), HCoV-HKU1 (",
            "AY884001",
            "), HCoV-OC43 (",
            "KF923903",
            "), HCoV-NL63 (",
            "NC_005831",
            "), and HCoV-229E (",
            "KY983587",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2669,
                "end": 2677,
                "name": "NC_04551"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2690,
                "end": 2698,
                "name": "FJ211859"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 2711,
                "end": 2720,
                "name": "NC_019843"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2734,
                "end": 2742,
                "name": "AY884001"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 2756,
                "end": 2764,
                "name": "KF923903"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 2778,
                "end": 2787,
                "name": "NC_005831"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 2805,
                "end": 2813,
                "name": "KY983587"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The maximum likelihood phylogenetic tree revealed that COVID-19 is found in the same clade of SARS-CoV; thus, the two strains are highly related to each other (Figure 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, ",
            "IEDB",
            " did not give any result for B-cell epitopes; this might be due to the length of the COVID-19 (75 amino acids)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 3002,
                "end": 3006,
                "name": "IEDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although both flu and anti-HIV drugs are used currently in China for treatment of COVID-19, chloroquine phosphate, an old drug for treatment of malaria, has recently been found to have apparent efficacy and acceptable safety against COVID-19 [77, 78]; nevertheless, more studies are required to standardize these therapies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, this is the first study to identify certain peptides in the envelope (E) protein as candidates for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within few weeks, the World Health Organization (WHO) announced a novel coronavirus designated as coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there is no vaccine or approved treatment for this emerging infection; thus, the objective of this study is to design a multiepitope peptide vaccine against COVID-19 using an immunoinformatics approach."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Extensive mutations, insertion, and deletion were discovered with comparative sequencing in the COVID-19 strain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the raging COVID-19 pandemic ongoing, the interaction between aging and immune response to the pathogen SARS-CoV-2 has attracted great attention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been widely reported that elderly people are more susceptible to COVID-19 and, once infected, the consequence is much more severe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The deaths associated with COVID-19 have been largely attributed to respiratory failure, sepsis, cardiac failure, kidney injury, or coagulopathy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Having quantified the changes in PBMC due to aging, the authors went on to analyze the interaction between aging and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Through a four-way comparison of young and old subjects with and without COVID-19, the authors found that COVID-19 infections lead to a depletion of TC and an increase of MC population, and in particular a depletion of CD4+ naive TC and increase of CD16+",
            "MC, and that aged subjects with COVID-19 further exacerbated these trends."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since CD16+ MC has highly pro-inflammatory properties (e.g., high expression of proinflammatory cytokines) compared with the non-CD16 expressing classic monocytes and are expanded in various inflammatory diseases (Ziegler-Heitbrock, 2007), the observation of Zheng et al., suggests that aging and COVID-19 act synergistically to drain the adaptive immune system and to exacerbate the overly inflammatory response that may be partially responsible for the severity of the infection in aged patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Future studies should examine the interactions between aging and other viral infections using a similar approach, to see whether the observed effect is general or specific to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three genetic-related models for predisposition to COVID-19 could be described: 1-Common variants in multiple loci that have weak effect through single contribution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2-Moderately rare variants in limited genes are expected to have strong effects, and thus be highly penetrant and even dominant trait as long as COVID-19 infection is considered."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concept of susceptibility to COVID-19 is getting more and more complex when gene interactions with environment factors, such as smoking, are considered (see Fig. 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The receptor-binding domain (RBD) of the COVID-19 spike-protein shows strong interaction with human angiotensin-converting enzyme 2 (ACE2) receptor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consequently, ACE2 genetic variants that could affect its gene expression, protein conformation, and protein stability are the one of most questionable underlying factors involving in genetic predisposition to COVID-19 infection [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It might be a clue to the higher prevalence and severity of COVID-19 in men than in women [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The immune-related genetic variants involving the prior strain of coronavirus, namely SARS-CoV, are suspected to have roles in genetic predisposition of COVID-19 infection [3], [4], since COVID-19 has 80% genetic identity to SARS-CoV [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 appears to be less severe in children [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For membrane fusion to occur–in comparison with other class-I fusion proteins and as described in coronavirus post-fusion structures– the S2 component is likely to undergo a major helical rearrangement, in which the long trimer interface helix (spanning residues 990–1035) grows and extends, by incorporating the refolded turn and helix from the N-terminal portion of HR1, and projects the fusion peptide towards the host cell membrane."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a crucial tool for fighting the COVID‐19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This dataset brief presents the exploration of a shotgun proteomics dataset acquired on SARS‐CoV‐2 infected Vero cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number and proportion of persons infected with COVID-19 are mainly determined based on individual testing and laboratory-based bio-molecular diagnostics using, e.g., reverse transcription-quantitative polymerase chain reaction (RT-qPCR)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 cases are reported by regional health authorities and aggregated on the level of, e.g., the Federal States in Germany, as well as on a national level (RKI, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Medema et al. (2020) have shown a good correlation between the number of COVID-19 cases and the gene concentration in the wastewater of different Dutch cities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences were identified in terms of the closest homology sequence using BLAST, https://blast.ncbi.nlm.nih.gov/Blast.cgi (database Nucleotide collection (nr/nt) using Blastn (optimized for somewhat similar sequences) or Megablast (optimized for highly similar sequences))."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Germany, local health authorities report the number of COVID-19 cases confirmed by laboratory diagnosis after aggregation from the community to district level to state and federal authorities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whenever available, the cumulative prevalence and the cumulative number of COVID-19 patients recovered and deceased were obtained from community-level reports published on the homepages of the responsible local health authorities on April 9th, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous evaluation of the primers and probe within a different test setting analysing patient material or cell culture-derived SARS-CoV-2 showed minor cross-reactivity with other human coronaviruses (data not shown)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While the sequence of the P12 PCR product showed significant similarity to SARS-CoV-2 sequence (isolate SARS-CoV-2/human/USA/CA-CZB-1525/2020; Accession: ",
            "MT628199.1",
            ") confirming the positive identification of human SARS-CoV2 by means of RT-qPCR (Supplementary Fig. S1A), no match to SARS-CoV-2 was detectable for C2 (Supplementary Fig. S1B)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1666,
                "end": 1676,
                "name": "MT628199.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, a positive BLAST result for C4 with SARS-CoV-2 synthetic construct (accession: ",
            "MT458696.1",
            ") (E value 0.002) (Supplementary Fig. S1C) was found."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1945,
                "end": 1955,
                "name": "MT458696.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When sequencing the different PCR amplicons obtained using wastewater samples taken during the SARS-CoV-2 pandemic and long before the outbreak (retained samples), distinct results for the test sample (P12) which fits SARS-CoV-2/human/USA/CA-CZB-1525/2020 isolate from ",
            "NCBI",
            " database was found, but not for the retained samples suggesting an unspecific signal in RT-qPCR, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2278,
                "end": 2282,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the day of our sampling campaign, we estimate the nominal acute incidence of COVID-19 to range between 30 and 174 cases per 100,000 residents in the nine catchment areas studied (Table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nine catchment areas studied differ considerably in size, wastewater flow (Table 2), and nominal numbers of COVID-19 cases at the day of sampling ranging from 36 to 1037 acute cases and from 85 to 1924 cumulative cases (Table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clearly, the estimated nominal number of COVID-19 cases increases with increasing measured SARS-CoV-2 load, resulting in correlations both for cumulative and acute prevalence (Fig. 8A and B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Concurrently, in the last weeks the relevance of the recent COVID‐19 (2019‐nCoV) outbreak and its effects started to become evident as everybody was monitoring the number of cases registered globally 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 26 January 2020, the first coronavirus disease 2019 (COVID-19) case was reported in Arizona (third case in the United States) (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In anticipation of COVID-19 spreading in Arizona, we initiated a surveillance effort for the local emergence of SARS-CoV-2 starting 24 January 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the estimated 1- to 14-day incubation period for COVID-19, the spike in cases might be related to university spring break holiday travel (8 to 15 March), as previously seen in other outbreaks (4, 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This generated an NGS data set of 20.7 to 22.7 million paired-end reads per sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GenBank",
            " and ",
            "GISAID",
            " accession numbers were the following: SARS-CoV-2 AZ-ASU2922, ",
            "MT339039",
            " and ",
            "EPI_ISL_424668",
            "; SARS-CoV-2 AZ-ASU2923, ",
            "MT339040",
            " and ",
            "EPI_ISL_424669",
            "; SARS-CoV-2 AZ-ASU2936, ",
            "MT339041",
            " and ",
            "EPI_ISL_424671",
            "; SARS-CoV-2 Wuhan1, ",
            "MN908947.3",
            "; Pangolin, ",
            "EPI_ISL_410721",
            "; Bat-RaTG13, ",
            "MN996532.1",
            "; and SARS-CoV, ",
            "AY278741.1",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 573,
                "end": 580,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 585,
                "end": 591,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 653,
                "end": 661,
                "name": "MT339039"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 666,
                "end": 680,
                "name": "EPI_ISL_424668"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 705,
                "end": 713,
                "name": "MT339040"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 718,
                "end": 732,
                "name": "EPI_ISL_424669"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 757,
                "end": 765,
                "name": "MT339041"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 770,
                "end": 784,
                "name": "EPI_ISL_424671"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 805,
                "end": 815,
                "name": "MN908947.3"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 827,
                "end": 841,
                "name": "EPI_ISL_410721"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 855,
                "end": 865,
                "name": "MN996532.1"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 881,
                "end": 891,
                "name": "AY278741.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T5"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T1",
                "end": "T7"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T1",
                "end": "T9"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T1",
                "end": "T11"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T1",
                "end": "T12"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T2",
                "end": "T6"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T2",
                "end": "T8"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T2",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "The 81-nt (27-amino-acid) deletion observed in SARS-CoV-2 AZ_ASU2923 ORF7a was not present in the 6,290 SARS-CoV-2 sequences available from ",
            "GISAID",
            " as of 12 April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1033,
                "end": 1039,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Chinese Centre for Disease Control and Prevention identified this infection as a novel coronavirus infection on Jan 7, 2020 and on Feb 11, 2020, the WHO announced a new name for the pandemic disease as 2019-new coronavirus disease (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Studies from Europe, China, and USA on COVID‐19 have consistently shown that older age and comorbidity are major risk factors for adverse outcomes and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although most reported COVID-19 cases in China were mild (81 %), approximately 80 % of deaths had occurred among adults population older than 60 years of age; only one (0.1 %) death had occurred in a person under 19 years of age [[3], [4], [5]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data from the UK [10] of more than 400 pregnant patients hospitalised with COVID-19 suggest an increased potential for adverse maternal outcomes in pregnant patients hospitalised with confirmed COVID-19 infection; while the risk of an intrauterine vertical transmission is inconclusive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Royal college of Obstetrics and Gynaecology recommends that delivery in COVID-19 patients should be determined primarily by obstetric indication and recommends against routine separation of affected mothers and their babies [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study aims to provide additional emerging information for maternity and neonatal services planning their response to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RT-PCR for SARS-CoV-2 nucleic acid was used to determine COVID-19 in suspected infection from both maternal and neonatal nasopharyngeal samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 6779 pregnant patients attended our Maternity unscheduled triaging system (Fig. 1",
            "), of which 79 had suspected COVID-19 symptoms for which nasopharyngeal samples for RT-PCR for SARS-CoV-2 nucleic acid were taken."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "23/79 (29 %) of patients had confirmed COVID-19 infection based on the RT-PCT test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For all the 23 patients, chest radiography also showed scattered multiple patchy infiltrates alongside ground glass appearances in both lungs consistent with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our cohort of 23 women, we had 19 pregnant women with confirmed COVID-19 in their 3rd trimester delivering 20 neonates (18 singleton, and 1 set of twins), and 4 women with confirmed COVID-19 in their second trimester."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One new-born, who was delivered at 35 weeks by emergency C-section to black African patient due to severe COVID-19 respiratory symptoms requiring ventilation, had low Apgar score of 3 and 5, at 1 and 5 min respectively following delivery (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, Chen et al. [5], and Zhu et al. [17] reported that the perinatal infection COVID-19 may have adverse effects on new-borns, but compared with SARS-CoV, the adverse mother-to-child outcomes are fewer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One pregnancy with confirmed COVID-19 infection in the third trimester had a neonate with intrauterine growth restriction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To study the effect of COVID-19 on pregnancy and neonatal outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We prospectively collected and analysed data for a cohort of 23 pregnant patients including singleton and multiple pregnancies tested positive for COVID-19 between February 2020 and April 2020 inclusive to assess the effect of COVID-19 on pregnancy, and neonatal outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twenty-three pregnant patients tested positive for COVID-19, delivering 20 babies including a set of twins, with four ongoing pregnancies at the time of manuscript submission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four out of total 23 COVID-19 pregnant patients (17.4 %) developed severe adult respiratory distress syndrome complications requiring ICU support, one of whom led to maternal death 1/23 (4.3 %)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  COVID-19 is associated with high prevalence of preterm birth, preeclampsia, and caesarean section compared to non−COVID pregnancies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 infection was not found in the newborns and none developed severe neonatal complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  Detection of SARS-CoV-2 viral RNA is important for the diagnosis and management of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antitumor capacity of these therapeutic NK cells can be further enhanced via incorporation of chimeric antigen receptors (CARs) or other engineered components."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of this writing, three global trials incorporating NK-cell based cellular therapies have been initiated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sampling dates were incorporated into TMRCA estimation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We downloaded 137 SARS-CoV-2 genomes available from ",
            "GISAID",
            " as of 2/23/2019."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 112,
                "end": 118,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All genome sequences were downloaded from ",
            "Global Initiative on Sharing Avian Influenza Data (GISAID",
            ", ",
            "https://www.gisaid.org/",
            ") and ",
            "GenBank",
            " (",
            "https://www.ncbi.nlm.nih.gov/nucleotide/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 178,
                "end": 235,
                "name": "Global Initiative on Sharing Avian Influenza Data (GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 237,
                "end": 260,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 266,
                "end": 273,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 275,
                "end": 315,
                "name": "https://www.ncbi.nlm.nih.gov/nucleotide/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Italy is one of the countries most- and earliest-affected in Europe by the COVID-19 pandemic (",
            "https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 94,
                "end": 191,
                "name": "https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first autochthonous cases of Coronavirus 2019 Disease (COVID-19) were observed starting from 21 February 2020 in Codogno (Lodi province), determining on 22 February 2020 the establishment of a “red zone” to contain the epidemic, encompassing 11 municipalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 59 SARS-CoV-2 whole genomes were newly-characterized from an equal number of patients affected by COVID-19, attending different clinical centres in Northern and Central Italy, from the beginning of the epidemic (22 February 2020) until 27 April 2020 (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results were mapped and aligned to the reference genome obtained from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ", accession ID: ",
            "EPI_ISL_412973",
            ") using Geneious software, v. 9.1.5 (Biomatters, Auckland, New Zealand) (http://www.geneious.com) [6] or Torrent Suite v. 5.10.1 (Euformatics Oy, Espoo, Finland) or BWA-mem and rescued using Samtools alignment/Map (Hinxton, UK) (v 1.9)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 806,
                "end": 812,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 814,
                "end": 837,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 853,
                "end": 867,
                "name": "EPI_ISL_412973"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The newly-characterized 59 genomes plus three previously characterized isolates by us (",
            "EPI_ISL_417445",
            "-417447) [1] were aligned with a total of 77 Italian sequences available in public databases (",
            "GISAID",
            ", ",
            "https://www.gisaid.org/",
            ") on 13 May 2020 and 452 genomes sampled in different European and Asian countries (513 and 16, respectively) representing all the different viral clades described in the ",
            "Nextstrain",
            " platform (",
            "https://nextstrain.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1191,
                "end": 1205,
                "name": "EPI_ISL_417445"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1299,
                "end": 1305,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 1307,
                "end": 1330,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1501,
                "end": 1511,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 1522,
                "end": 1545,
                "name": "https://nextstrain.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "The final data set thus included 588 sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sampling dates of the entire dataset ranged from 30 December 2019 to 27 April 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table S2 shows the accession IDs, sampling dates and locations of the sequences included in the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic analysis for clade assignment was performed by RaxML [11] on the entire dataset of 588 genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A root-to-tip regression analysis was made using TempEst in order to investigate the temporal signal of the dataset [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two from Chinese patients visiting Italy at the end of January 2020 after being infected in Wuhan and one characterized by us from an Italian subject, living in Padua, sampled in March 2020, not reporting any recent trip outside Italy or contacts with subjects affected by COVID-19 (pp = 0.99) (Figure 1, clade 19A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Italy, values between 2.4 and 3.6 have been estimated in the early phase of COVID-19 epidemic before the control measures were taken [23,24,25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed that the Re was >1 since the first decade of February, suggesting that the infection was circulating within the population before the first notified (hospitalized) COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since early February, an effective reproduction number (R e ) greater than 1 was estimated, which then increased reaching the peak of 2.3 in early March, confirming the circulation of the virus before the first COVID-19 cases were documented."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A new virus-associated disease, coronavirus disease 2019 (COVID-19), was initially reported in China on 30th December 2019 (Wu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The causative agent of COVID-19 is the novel human coronavirus SARS-CoV-2 (Wu et al., 2020, Zhou et al., 2020), and, as of 24th March 2020, there have been 372,757 confirmed infections and 16,231 deaths reported worldwide (World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In China, the COVID-19 epidemic grew exponentially during January 2020, peaking on 12th February 2020 with 15,153 newly confirmed cases per day."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One month later, reported COVID-19 cases in China dropped to ~20 per day, indicating the epidemic there was contained."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By 11th March 2020, the day that the World Health Organization (WHO) announced COVID-19 to be a new pandemic, 37,371 cases had been reported outside of China (World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results may provide valuable information for implementing and interpreting genomic surveillance of COVID-19 in other regions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 cases in Guangdong grew until early February 2020 (peaking at >100 cases per day) and declined thereafter (Figure 1",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, since the beginning of March 2020 COVID-19 cases imported into Guangdong from abroad have been detected with increasing frequency."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 26th March 2020, a total of 102 imported cases were reported from 19 different countries (Figure 1A), highlighting the risk that local COVID-19 transmission could reignite in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More intensive surveillance was initiated on 30th January 2020 in response to the Spring Festival period, which results in greater mobility among regions and provinces in China (Kraemer et al., 2020, Tian et al., 2020) and because asymptomatic COVID-19 cases had been reported (Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Surveillance commenced at Guangdong airports in early March, following the growth of COVID-19 outbreaks outside of China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand the genetic structure of the COVID-19 outbreak in Guangdong, we generated near-complete and partial genomes from 53 COVID-19 patients in Guangdong Province."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median tMRCA estimate of the COVID-19 pandemic was 1st December 2019 (95% HPD 15th November to 13th December 2019; Figure 4), consistent with previous analyses (Rambaut, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analyses of the genomic epidemiology of SARS-CoV-2 in Guangdong province indicate that, following the first COVID-19 case detected in early January, most infections were the result of virus importation from elsewhere, and that chains of local transmission were limited in size and duration."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, vigilance is still required as there remains a risk that SARS-CoV-2 transmission could reignite in Guangdong following the recent increase in the number of COVID-19 cases imported to China from other countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further, the low and variable sampling of COVID-19 cases among different regions makes it challenging to evaluate phylogenetic clusters that comprise cases from a single region; although such clusters could indeed represent local transmission, our results show they can also include multiple introductions from a genomically undersampled location."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The accession numbers for the sequences reported in this paper are ",
            "GISAID",
            ": ",
            "EPI_ISL_413850–413902",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 3145,
                "end": 3151,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 3153,
                "end": 3174,
                "name": "EPI_ISL_413850–413902"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Suspected COVID-19 cases were screened by 31 designated hospitals, local CDCs in 21 prefecture cities, and 6 third-party detection institutions with commercial real-time reverse transcription PCR (RT-PCR) kits (see below for further details)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These cities recorded the highest number of COVID-19 cases (Figure 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We collected a further 21 samples from 18 patients from a screening project of hospitalized COVID-19 cases in Guangdong, which was launched on 28th February."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Virus genomes were generated by two different approaches, (i) untargeted metagenomic sequencing on the BGI MGISEQ-2000 (n = 63) and Illumina NextSeq (n = 4) sequencing platforms, and (ii) using version 1 of the ARTIC COVID-19 multiplex PCR primers (https://artic.network/ncov-2019), followed by nanopore sequencing on an ONT MinION (n = 45)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ARTIC bioinformatics pipeline for COVID (https://artic.network/ncov-2019) was used to generate consensus sequences and call single nucleotide changes relative to the reference sequence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Assembly of the nanopore raw data was performed using the ARTIC bioinformatic pipeline for COVID-19 with minimap2 (Li, 2018) and medaka (https://github.com/nanoporetech/medaka) for consensus sequence generation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All available SARS-CoV-2 sequences (n = 323) on ",
            "GISAID",
            " (",
            "gisaid.org",
            ") on 13th March 2020 were downloaded."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 4441,
                "end": 4447,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 4449,
                "end": 4459,
                "name": "gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Sequences from ",
            "GISAID",
            " that were error-rich, those which represented multiple sequences from the same patient, and those without a date of sampling were removed."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 4512,
                "end": 4518,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the dataset was reduced by only retaining the earliest and most recently sampled sequences from epidemiologically linked outbreaks (e.g., the Diamond Princess cruise ship)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resulting dataset of 250 sequences therefore represents the global diversity of the virus while minimizing the impact of sampling bias."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Root-to-Tip Genetic Distance for 250 Sequences in the Maximum Likelihood Tree Plotted against Collection Date, Related to Figure 3",
            "Details of the Clusters (A–E) of Guangdong Genome Sequences, Related to Figure 3",
            "Screenshots of the Online Tree Visualization Tool, Related to Figure 3",
            "Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first reported in central China in December 2019."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite these successes, COVID-19 surveillance in Guangdong is still required, because the number of cases imported from other countries has increased."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Effective control measures helped reduce and eliminate chains of viral transmission      Genomic and epidemiological analyses provide insights into how COVID-19 was contained in China’s most populous province using a combination of surveillance and travel restriction measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the problems raised by the COVID-19 pandemic, there is the increased risk of exposure of healthcare workers to the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Forster et al. (1) use a median-joining (MJ) network (MJN) and its Steinerization process to investigate the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) within humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because their work may have profound implications for understanding and managing the COVID-19 global pandemic, scrutiny is necessary."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, the implication that MJNs reflect phylogenetic signal in the traditional sense has previously been challenged by Kong (3), who compared inference based on MJNs with Bayesian model-based phylogenetic inference for 85 published datasets and found substantial disagreement between inferred MJNs and posterior distributions on phylogenies, indicating that the two methods provide different measures of relatedness in a phylogenetic sense."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic caused by the novel coronavirus SARS-CoV-2 (COVID-19) has resulted in significant pulmonary morbidity and mortality, but has also raised many questions regarding involvement of other organ systems such as the liver."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hepatologists and liver pathologists were therefore interested to find that researchers from China demonstrated liver function test (LFT) abnormalities in ~44% of COVID-19 patients and that these abnormalities seemed to correlate with the severity of pulmonary disease [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nonetheless, the spectrum of histological liver injury in COVID-19 remains unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early in the course of the pandemic, New York City was the global epicenter for cases of, and deaths from, COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our volume of autopsies increased sharply, and most of the cases were due to sequelae of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lung findings predominated, as expected; however, ~2/3 of COVID-19 patients in our healthcare system had abnormal LFTs [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following approval from the Columbia University Irving Medical Center Institutional Review Board, we reviewed lung and liver sections from 40 consecutive autopsies from patients who died of illness related to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Quantitative RT-PCR was performed on extracted RNA using Taqman 4X master mix and SARS-COV-2 primer/probe sets (IDT) to detect presence of virus per the CDC recommendations [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sequentially examined the liver sections of the first 44 COVID-19 autopsies at our institution; however, four were excluded for severe autolysis resulting in a cohort of 40 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This patient had been treated with a number of potentially hepatotoxic medications throughout the hospital course including hydroxychloroquine and tocilizumab for severe COVID-19, as well as amiodarone for atrial fibrillation and ceftriaxone and piperacillin/tazobactam for infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, it would seem likely that the steatosis in some of these cases developed during the course of their COVID-19 illness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A series of over 300 COVID-19 cases in China investigated the relationship between steatosis and neutrophil to lymphocyte ratio (NLR)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The exact mechanism/pathobiology of hepatic steatosis in COVID-19 is worthy of further investigation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The role of immunosuppression and allograft recipient status on liver injury associated with COVID-19 will need further study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The potential role of endothelial injury in COVID-19 continues to evolve."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While we cannot exclude these findings being meaningful (if they are present throughout the entire liver), we do not believe that vascular injury is the major mechanism of injury in the liver in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the epidemic evolves, it will be important to gather data on liver injury in patients with non-lethal COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We attempted to validate in-situ hybridization (ISH) protocols and IHC for SARS-CoV-2, but nonspecific marking of lipofuscin, and reaction with endogenous alkaline phosphatase in liver tissue from non-COVID-19 patients who died years ago was nearly ubiquitous (sometimes strong and diffuse)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It will be important and interesting to attempt to identify virus in specific cells in the liver and to determine whether the ACE2 receptor is upregulated in hepatocytes in patients with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus SARS-CoV-2 (coronavirus disease 19, or COVID-19) primarily causes pulmonary injury, but has been implicated to cause hepatic injury, both by serum markers and histologic evaluation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we report the clinical and histologic findings related to the liver in 40 patients who died of complications of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, we found patients dying of COVID-19 had biochemical evidence of hepatitis (of variable severity) and demonstrated histologic findings of macrovesicular steatosis and mild acute hepatitis (lobular necroinflammation) and mild portal inflammation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since December 2019, coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a worldwide panic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent clinical studies have observed digestive symptoms in patients with COVID-19,1 possibly because of the enrichment and infection of SARS-CoV-2 in the gastrointestinal tract, mediated by virus receptor of angiotensin converting enzyme 2 (ACE2), which suggests the potential for a fecal-oral route of SARS-CoV-2 transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "However, there is still a large gap in the biological knowledge of COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical and epidemiologic data of patients with COVID-19 were collected from a continually updated resource."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The transcriptome and proteome derived from bulk tissues and cells were accessed from multiple databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A phenome-wide association study data set was supplied for genetic analysis on the ACE2 pathway."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We constructed a user-friendly interface for the visualization of clinical symptoms of COVID-19 (https://mulongdu.shinyapps.io/map_covid/;",
            "A similar expression pattern could be found in extra data sets (Figure 1",
            "B–D)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; DLBC, Lymphoid neoplasm diffuse large B-cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and Neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower-grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; MESO, mesothelioma; ns, no significance; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SARC, sarcoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THY, thymoma; TPM, transcripts per million; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma; UHR, Universal Human Reference RNA; UVM, uveal melanoma."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We obtained 7 phenotypes related to the intestinal tract and kidney deposited in the phenome-wide association study data set and extracted genome-wide association study summary statistics with more than 3000 single-nucleotide polymorphisms assigned to 33 genes of the ACE2 pathway for the gene set analysis (Supplementary Table 2 and Supplementary Figure 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was corroborated by the clinical observation that the patients with severe cases of COVID-19 were more likely to have a smoking history (22.1%) than those with nonsevere COVID-19 (13.1%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, renal impairment was common in patients with severe COVID-19, which could be supported by the potential that SARS-CoV-2 damaged renal tubular cells and induced the disruption of the ACE2 pathway referring to ACE2, ACE, ENPEP, TGFB1, THOP1, MAS1, and NLN involved in kidney dysfunction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is reasonable to emphasize the monitoring of digestive and excretory system complications in patients with COVID-19 and the possibility of SARS-CoV-2 transmission via the fecal-oral route by individuals with suspected infection and asymptomatic carriers (Supplementary Figure 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Their positions on the 3D structure of the MERS-CoV spike protein (",
            "PDB",
            " ID: ",
            "5X5F",
            ") are illustrated in Figure 3."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 67,
                "end": 70,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 75,
                "end": 79,
                "name": "5X5F"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For the sake of comparison, we also retrieved 21 complete genomes of betacoronavirus strains from the ",
            "National Center for Biotechnology Information (NCBI)",
            " database (",
            "http://www.ncbi.nlm.nih.gov/genomes/VirusVariation/Database/nph-select2.cgi",
            "), along with those of two 2019-nCoV strains isolated in Saudi Arabia (",
            "https://www.gisaid.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 212,
                "end": 264,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 275,
                "end": 350,
                "name": "http://www.ncbi.nlm.nih.gov/genomes/VirusVariation/Database/nph-select2.cgi"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 421,
                "end": 443,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Primers were designed and checked using Primer Express software (v3.0) (Applied Biosystems, Foster City, CA, USA) and NetPrimer (Premier Biosoft, Palo Alto, CA, USA), with gap flanking regions incorporated into the primers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the spike protein dataset, we used the Blosum62+Gamma substitution model, a strict clock model, and a constant-size tree prior."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The BEAST package TreeAnnotator was utilized to summarize a maximum clade credibility (MCC) tree for every dataset using MCMC tree samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the currently ongoing COVID-19 pandemic that has caused over 15 million reported cases worldwide and over 600,000 deaths as of July 2020, also contains the heavily glycosylated surface glycoprotein spike (S) protein."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because no vaccines or therapeutics are currently available for COVID-19, studies of SARS-CoV-2 as a prime target for anti-viral lectins, especially those that bind to complex-type N-glycans, are of special interest and substantial importance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 50% infective dose (TCID50) and immunoplaque assay (PFU/ml) of viruses in MDCK or Vero E6 cells were determined beforehand."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings suggest a potential application of FRIL for the prevention and/or treatment of influenza and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For a coordinated long-term response to epidemic threats, including COVID-19, Canadian researchers should coordinate their data collection and data governance practices with those of established international consortia to facilitate efficient data deposit (Council of Canadian Academies 2015)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has lain bare the fault lines in Canada’s health data regulation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Challenges faced in sharing health data to respond to the COVID-19 epidemic demonstrate how Canada’s duplicative privacy legislation can create considerable barriers for health data sharing in Canada with minimal gains in personal privacy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consequently, we suggest inhibition of E protein can be a good target to alleviate ARDS complication of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These ",
            "GenBank",
            " annotations contain heterogeneous identifiers for genes so we included unique locus tags containing the strain accession number and gene index number for computational processing."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 120,
                "end": 127,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other databases showing greater detail about many viruses, such as ",
            "Virus Pathogen Resource (VIPR",
            ", ",
            "https://www.viprbrc.org",
            ") and ",
            "GSAID",
            " (",
            "https://www.gisaid.org",
            ") are very useful but these resources do not provide gene clustering or pan-genome analysis."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 375,
                "end": 404,
                "name": "Virus Pathogen Resource (VIPR"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 406,
                "end": 429,
                "name": "https://www.viprbrc.org"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 435,
                "end": 440,
                "name": "GSAID"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 442,
                "end": 464,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "We used all genes from Betacoronavirus dataset in order to explore Gene Ontology predictions through our in-house DeepGOPlus (Kulmanov and Hoehndorf, 2020) tool that combines deep convolutional neural network (CNN) model with sequence similarity-based predictions to derive relevant functional classes from Gene Ontology alongside a confidence score."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To validate the conservation and specificity of the SARS E cluster, we compared the SARS-CoV-2 E sequence with all known sequences in ",
            "NCBI's non-redundant (NR) protein",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1042,
                "end": 1075,
                "name": "NCBI's non-redundant (NR) protein"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a blast-based search against the DNA of all sequences in ",
            "NCBI's NT",
            " database showed that the ORF10 sequence matches with 100% coverage in DNA of other SARS-like genomes, but there is no open-reading frame predicted for those genomes in the matching region (Figure 1A)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1152,
                "end": 1161,
                "name": "NCBI's NT"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, our analysis is in agreement with ORFs 3a, 6, 7a, 8, and being accessory non-essential proteins, that would be inefficient targets for COVID-2019 therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of isolates from COVID-19 patients are now being made available from several countries, thanks to resources such as gisaid.org."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the conservation of the key features of E proteins from SARS anSARS-CoV-2, these compounds would be promising candidates for inhibiting ARDS in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Such more indirect targeting of the protein E function might also be considered for COVID-19 therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therapies to combat the spread of SARS-CoV-2 and the lethality caused by the resulting COVID-2019 are currently focusing primarily on S, the viral spike protein (Kruse, 2020; Liu et al., 2020; Wrapp et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our pangenomic analysis suggests that the protein E of all SARS viruses preserves its critical motifs used for pathogenesis, and should be considered as an alternative target to be tested for therapies to mitigate COVID-2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All datasets presented in this study are included in the article/Supplementary Material and ",
            "https://pangenomedb.cbrc.kaust.edu.sa",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 2459,
                "end": 2496,
                "name": "https://pangenomedb.cbrc.kaust.edu.sa"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Together with functional pangenomic analysis, mutation tracking, and previous evidence, on E protein as a determinant of pathogenicity in SARS, we suggest E protein as an alternative therapeutic target to be considered for further studies to reduce complications of SARS-CoV-2 infections in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a CoV identified as the causal agent of the respiratory epidemic first detected in China (Wuhan) and subsequently declared by the World Health Organization (WHO) as the COVID-19 pandemics due to the spread of the outbreak to other countries worldwide (Lai et al., 2020; Zheng, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has caused a significant loss in human lives and has resulted in a tremendous economic damage across the five continents (Ahn et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, there is no accurate therapy for COVID-19 though some medications such as chloroquine/hydroxychloroquine (Wright et al., 2020), combinations of antiviral and anti-inflammatory treatments (Stebbing et al., 2020), traditional Chinese medicine (Ren et al., 2020) and other therapeutics (Ahn et al., 2020; Elfiky, 2020) have been proposed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The development of vaccines against COVID-9 is also at its infancy (Ahmed et al., 2020; Prompetchara et al., 2020; Robson, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to the extent of the pandemic, experimental research on COVID-19 vaccine candidates and therapeutics as well as the identification of suitable experimental models are needed to limit the impact of SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the outbreak of COVID-19, scientists have put forward effort to analyze the codon usage bias of CoVs in order to improve our understanding on the emergence, adaptation, spread and evolution of SARS-CoV-2 (Tort et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a systems biology approach, network-pharmacology has been also used for evaluating the potential of traditional Chinese medicines against COVID-19 (Yu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In silico prediction of drug candidates against COVID-19 has been also proposed on the basis of Angiotensin converting enzyme 2 (ACE2) regulatory network (Cava et al., 2020); however, this prediction had no direct connection with viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, systems biology approaches based on codon usage co-adaptation between SARS-CoV-2 and its human host as well as SARS-CoV-2-induced differential gene expression have not been applied for discovering potential therapeutics for COVID-19 and other respiratory CoVs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, the primary purpose of the present study was to use systems biology approaches for analyzing the codon usage profile of SARS-CoV, SARS-CoV-2 and MERS-CoV in order to provide useful molecular data for the development of attenuated SARS-CoV-2 vaccine strains that may have vaccine potential against COVID-19 and a broader applicability for CoVs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, based on our knowledge of these genes, we also aimed to predict, in silico, the potential drugs for the treatment of the ongoing COVID-19 in particular, and CoV infection in general."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the model of CAI, ENc-GC3 and RSCU of the three CoVs, we uncovered the functional role of CoV-responsive human genes and how respiratory CoVs affect human genes, and revealed a useful set of drugs that could guide practitioners in strategical monitoring of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The full-length CDS sequences of SARS-CoV, SARS-CoV-2 and MERS-CoV were downloaded from the ",
            "NCBI",
            " virus (",
            "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/",
            ") database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 3047,
                "end": 3051,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 3059,
                "end": 3104,
                "name": "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The gene expression dataset ",
            "GSE147507",
            " (",
            "Blanco-Melo et al., 2020",
            ") containing the gene expression of human cells transfected or untransfected with SARS-CoV-2 was downloaded from the ",
            "GEO",
            " database(",
            "https://www.ncbi.nlm.nih.gov/geo/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 3144,
                "end": 3153,
                "name": "GSE147507"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 3155,
                "end": 3179,
                "name": "Blanco-Melo et al., 2020"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 3296,
                "end": 3299,
                "name": "GEO"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 3309,
                "end": 3342,
                "name": "https://www.ncbi.nlm.nih.gov/geo/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T6"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T3"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The ",
            "viruSITE",
            " (",
            "http://www.virusite.org/",
            "), a database of viral genomes and genes (",
            "Stano et al., 2016",
            "), was used for analyzing the sequences of SARS-CoV, SARS-CoV-2 and MERS-CoV based on the reference sequences deposited in this database."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 3349,
                "end": 3357,
                "name": "viruSITE"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 3359,
                "end": 3383,
                "name": "http://www.virusite.org/"
            },
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 3425,
                "end": 3443,
                "name": "Stano et al., 2016"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T9",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "PCA is a multivariate analysis approach that is used for geometrical plotting of sets of columns and rows in a given dataset (Wold et al., 1987)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to examine the genomic similarity of SARS-CoV, SARS-CoV-2 and MERS-CoV, similarity analysis was performed using the ",
            "viruSITE",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 3852,
                "end": 3860,
                "name": "viruSITE"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the ",
            "Drug-Gene Interaction database (DGIdb)",
            ", we identified drug candidates targeting the potential human genes affected by viral infection."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 3881,
                "end": 3919,
                "name": "Drug-Gene Interaction database (DGIdb)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the remaining genes we found hydroxychloroquine (3 target genes) and chloroquine (2 target genes) which have been recently proposed as therapeutics for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We inferred that the list of drugs found in this study could be useful for the treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This approach could be adopted in the search for vaccines against respiratory viruses such as the SARS-CoV2 responsible for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, the mechanism underlying the pathogenesis of COVID-19 is unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, recent studies have reported that segmental pulmonary emboli (hemoptysis) occurs in COVID-19 infection (Casey et al., 2020), which corroborated with our finding that the pathway of hematopoietic cell lineage is potentially dysregulated in CoV infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there is no precise therapy for treating the ongoing COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we predicted a set of drugs that could be efficient in the treatment of COVID-19 and other CoV infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the early search of treatment for SARS-CoV-2 infection, researchers have proposed hydroxycholoroquine and chloroquine as treatment for COVID-19 (Singh et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study also predicted these drugs as a treatment for COVID-19 and other CoV infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, we believe that its administration to CoV-infected patients will probably be salutary for patients especially due to the fact that studies have demonstrated that the neuroinvasive ability of SARS-CoV2 is partially associated with the respiratory failure of COVID-19 patients (Li et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) has caused thousands of deaths worldwide and has become an urgent public health concern."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Herein, based on publicly available genomic data, we analyzed the codon usage co-adaptation profiles of SARS-CoV-2 and other respiratory coronaviruses (CoVs) with their human host, identified CoV-responsive human genes and their functional roles on the basis of both the relative synonymous codon usage (RSCU)-based correlation of viral genes with human genes and differential gene expression analysis, and predicted potential drugs for COVID-19 treatment based on these genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the drug-gene interaction database, we screened a list of drugs that could target these genes as potential COVID-19 therapeutics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings not only will contribute in vaccine development but also provide a useful set of drugs that could guide practitioners in strategical monitoring of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We recommend practitioners to scrupulously screen this list of predicted drugs in order to authenticate those qualified for treating COVID-19 symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus disease, named COVID-19, responsible for SARS, appeared in late 2019, originating most likely from a seafood market in Wuhan, in the Hubei province of China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "3",
            "COVID-19 infection has rapidly spread and was declared a pandemic by the WHO on 11 March 2020."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An analysis of 1524 patients admitted to a radiation and medical oncology unit in Wuhan from December 2019 to February 2020 found a twofold increase of the risk of COVID-19 infection rate in patients with cancer compared with the general population (0.79% vs 0.37%) over the same period of time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "5 Data derived from a nationwide analysis in China reported that COVID-19-positive patients with cancer (N=18) had a higher risk of severe events compared with patients without cancer (39% vs 8%, p=0.0003), especially patients in active treatment compared with cancer survivors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Facing this exceptional and rapidly developing situation, no standard operating procedures for care organisations existed in oncologiocal institutions, although general recommendations for healthcare in hospital units, for COVID-19 and suspected case management were rapidly drafted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to assess how oncology centres and departments reacted to the health crisis related to the COVID-19 pandemic, in order to improve oncological care and to implement preventive measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A survey (online supplementary material) was sent by email to 30 representatives of oncological departments in 12 of the most affected countries by COVID-19 in Europe and the USA in order to provide quality assessment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The burden on the health system for each country at the moment of the survey completion was reported as the number of affected cases per 100 000 inhabitants, with data extracted from the ",
            "Johns Hopkins University COVID-19 Data Repository",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1734,
                "end": 1783,
                "name": "Johns Hopkins University COVID-19 Data Repository"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The burden of COVID-19 cases on the health system is calculated as the number of total infections per 100 000 inhabitants in each country (figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For Italy, Belgium, Switzerland, Spain and the other centre from USA, 200–400 patients were affected by COVID-19 per 100 000 inhabitants."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In 10/21 (47.6%) centres, physicians discussed the option to avoid intensive care in case of worsening of clinical conditions in those with terminal illness, regardless of COVID-19 infection, accepting the risk of early death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In 13/20 (65%) centres, swab tests were performed before hospitalisation, and in 10/20 (50%) centres, admissions were limited to COVID-19-negative patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although some legal and reimbursement issues remain, COVID-19 crisis has led to a rapid expansion of telemedicine, which could remain a good option also outside the pandemic crisis, especially when a clinical examination is not necessary and in areas of the world where reaching the hospital raises practical difficulties for patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chest CT scan seems to be more sensitive than RT-PCR for COVID-19 diagnosis and in 60%–93% of the cases becomes positive before the RT-PCR.25 27 However, the disadvantage of CT is the limited availability in terms of number of exams per day in each institution compared with the swab, which can be easily made on a large scale and is less cost-effective."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "32 33",
            "Finally, predisposed dedicated facilities to manage cancer care during COVID-19 pandemic could be advisable."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "34 Although COVID-19 wards have been organised in most centres, in only 57.1% of the centres healthcare professionals caring for oncohaematological patients did not take part in the care of COVID-19-positive patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although some recommendations for hospital management during the COVID-19 pandemic are actually available, such as those of the European Centre for Disease Prevention and Control, our study allows assessment of adherence to this recommendation, in addition to providing an insight into the management of oncological care during the pandemic in a real-world context."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  COVID-19 appeared in late 2019, causing a pandemic spread."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathophysiology of severe coronavirus disease 2019 (COVID-19) is similar to that of severe disease caused by SARS-CoV and is characterized by acute respiratory distress and excessive inflammation capable of inducing respiratory failure, multi-organ failure, and death (Wong et al., 2004; Zhang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These characteristics contribute to the difficulty of containing SARS-CoV-2 spread through public health strategies and amplify the need to develop vaccines and therapies to protect against and treat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical management of COVID-19 is largely limited to infection prevention and supportive care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So far, remdesivir, a broad-spectrum antiviral agent, is the only medication approved for emergency use to treat COVID-19 by the US Food and Drug Administration (FDA) (Grein et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the evidence supporting remdesivir use in patients with advanced COVID-19 is promising, there remains an urgent need for potent SARS-CoV-2 therapeutic agents, especially those that could be given in an outpatient setting, to effectively combat the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Quality control filtering of the data was performed, and two samples from each of the phosphorylation and protein abundance datasets were removed because of poor correlation with their respective replicates (Figures S1",
            "A and S1B)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The downregulation of these proteins suggests that they may mechanistically contribute to symptoms of blood coagulation and stroke in COVID-19 patients (Han et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We detected 25 phosphorylation sites in SARS-CoV-2 viral proteins that we combined with another proteomics dataset (",
            "Davidson et al., 2020",
            ") to amass a total of 49 sites detected across seven viral proteins (Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1603,
                "end": 1624,
                "name": "Davidson et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dot color indicates whether the residue is (true) or is not (false) predicted to form part of an interaction interface based on SPPIDER analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify phosphorylation sites that may regulate protein-protein interactions, all sites were mapped to 3D structures, and solvent accessibility based protein-protein interface identification and recognition (SPPIDER) was used to assess whether sites resided within interface regions (Porollo and Meller 2007; Figure 2A; Table S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Kinase activities were estimated for a wide-range of biological conditions obtained from previously published phosphoproteomics datasets (",
            "Ochoa et al., 2016",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 2323,
                "end": 2341,
                "name": "Ochoa et al., 2016"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better understand the signaling states of cells over the course of infection, we compared our data with a compilation of public phosphoproteomics datasets of other conditions (",
            "Ochoa et al., 2016",
            "; Figures 4D and S2B)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 2523,
                "end": 2541,
                "name": "Ochoa et al., 2016"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparing phosphoproteomics profiles of SARS-CoV-2-infected cells with a database of phosphorylation profiles collected at specific cell cycle stages, viral infection was most highly correlated with cells arrested at the S/G2 transition and was negatively correlated with profiles of cells in mitosis (Figure 6G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, 68 total drugs and compounds were tested for antiviral efficacy (via qRT-PCR, anti-NP antibody, plaque assay, and/or TCID50) and cellular toxicity at two different institutions (in New York [Mount Sinai, 25 drugs/compounds] and Paris [Institut Pasteur, 62]) and in two cell lines (Vero E6 [68] and A549-ACE2 [61])."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, silmitasertib is currently being considered for human testing as a potential treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent immunological studies have indicated that increased IL-6, IL-10, and TNF-α and lymphopenia are associated with severe COVID-19 cases (Pedersen and Ho 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, during SARS-CoV-2 infection, p38/MAPK inhibition suppressed cytokine production and impaired viral replication by a still unknown mechanism, suggesting that p38/MAPK inhibition may target multiple mechanisms related to COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Silmitasertib, a small molecule undergoing clinical trials for various cancers, is now being considered for testing in humans to combat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antiviral activity observed for gilteritinib, an FDA-approved drug for treatment of acute myeloid leukemia, is supported by involvement of another AXL inhibitor, bencentinib, in the RECOVERY COVID-19 clinical trial in the United Kingdom."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mass spectrometry proteomics data have been deposited to the ",
            "ProteomeXchange Consortium",
            " via the ",
            "PRIDE",
            " partner repository with the dataset identifier ",
            "PXD019113",
            " (",
            "Perez-Riverol et al.",
            ", 2019)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 4185,
                "end": 4211,
                "name": "ProteomeXchange Consortium"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 4220,
                "end": 4225,
                "name": "PRIDE"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 4273,
                "end": 4282,
                "name": "PXD019113"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 4284,
                "end": 4304,
                "name": "Perez-Riverol et al."
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "For infection experiments in ACE2-A549 cells, SARS-CoV-2, isolate USA-WA1/2020 (NR-52281), which shares 99.983% sequence identity with the BetaCoV/France/IDF0372/2020 isolate, was deposited by the Center for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Raw mass spectrometry data from each DDA dataset were used to build separate libraries for DIA searches using the Pulsar search engine integrated into Spectronaut version 13.12.200217.43655 (Bruderer et al., 2015) by searching against a database of ",
            "Uniprot",
            " Chlorocebus sequences (19,136 proteins, downloaded April 3, 2020) and 29 SARS-CoV-2 protein sequences translated from genomic sequence downloaded from ",
            "GISAID",
            " (accession ",
            "EPI_ISL_406596",
            ", downloaded April 7, 2020) with two mutations (G22661T Spike V367F and G26144T ORF3a G251V) detected by RNASeq analysis of virus stocks."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 4849,
                "end": 4856,
                "name": "Uniprot"
            },
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 5008,
                "end": 5014,
                "name": "GISAID"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 5026,
                "end": 5040,
                "name": "EPI_ISL_406596"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "This complex dataset was reduced to a single fold change per site and time point by choosing (per time point) the fold change with the lowest p value, favoring those detected in both treatment and control, i.e., non-infinite log2 fold change values."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This single-site dataset, further reduced to those with human orthology (Table S1), was used as the input for kinase activity analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significance filters of adjusted p value < 0.05 and absolute log2 fold change (infected/mock) > 1 were applied to both phosphorylation and abundance datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resource comprises of a comprehensive collection of phosphosite annotations of direct substrates of kinases obtained from six databases, PhosphoSitePlus, SIGNOR, HPRD, NCI-PID, Reactome, and the BEL Large Corpus, and using three text-mining tools, REACH, Sparser, and RLIMS-P. Kinase activities were inferred as a -log10(p value) of Z-test from the comparison of fold changes in phosphosite measurements of the known substrates against the overall distribution of fold changes across the sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to the time-course experiment, we also estimated kinase activities of cell line perturbation in a range of biological conditions using the K-test based approach, from a large resource of previously published phosphoproteomics datasets comprising of 435 biological conditions which include several drug treatments (chlorzoxazone, paclitaxel), inhibitors (EGFRi, AKTi) and cell cycle states (",
            "Ochoa et al., 2016",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Creator",
                "start": 6625,
                "end": 6643,
                "name": "Ochoa et al., 2016"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Annotations for protein complexes were obtained from CORUM v3.0 database (Giurgiu et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate the effect of SARS-CoV-2 infection at the Transcription Factor (TF) level, we applied DoRothEA (Garcia-Alonso et al., 2019) to RNA-seq datasets of different human lung cell lines from a recent study (",
            "GSE147507",
            ") (",
            "Blanco-Melo et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 6955,
                "end": 6964,
                "name": "GSE147507"
            },
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 6967,
                "end": 6991,
                "name": "Blanco-Melo et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For TCID50 and plaque assay results, which are not depicted in a percent scale, the IC50 values were extracted directly from the parameterized hill equation (see Figure S5 and Table S8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop antiviral therapies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found pharmacologic inhibition of the p38, CK2, CDK, AXL, and PIKFYVE kinases to possess antiviral efficacy, representing potential COVID-19 therapies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "] both of which are clinical manifestations observed in hospitalized patients infected by SARS‐CoV‐2 and suffering from COVID‐19.["
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As new CoVID policies and responses are implemented to lessen the impact of the virus, it is imperative (1) to consider additional mitigation strategies critical for the development of effective countermeasures, (2) to promote long-term policies and strict regulations of the trade of wildlife and live animal markets, and (3) to advocate for necessary funding and investments in global health, specifically for the prevention of and response to natural and manmade pandemics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], which shares high genetic similarity with the most closely-related bat origin SARS-like virus (RaTG13) [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The design of risk assessments and successful interventions for COVID-19 now depend on how well we understand the course of SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic is underway [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Social measures for monitoring, controlling and treating COVID-19 vary among and within countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been suggested that the detection of antibodies to SARS-CoV-2 could serve as the basis for an “immunity passport”, however it is currently unclear whether recovered COVID-19 cases have neutralizing antibodies that protect them from a second infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There have been reports that some recovered COVID-19 cases have re-tested positive for SARS-CoV-2 RNA some time after discharge [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Guangdong Province reported the highest number of COVID-19 cases in China except Hubei."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Guangdong launched an enhanced surveillance network and a series of intervention measures in response to the outbreak soon after the first COVID-19 case was reported in December 2019 [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since 23 January, all discharged COVID-19 cases were isolated in designated hotels under medical observation for another 14 days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we screened 619 recovered COVID-19 cases in Guangdong discharged between 23 January and 19 February."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Discharge criteria for COVID-19 cases in Guangdong include: 1) body temperature is normal for more than three days, 2) respiratory symptoms including fever, dry cough and tiredness noticeably improve, 3) pulmonary imaging shows obvious absorption of inflammation, and 4) nucleic acid tests are negative twice consecutively, on both respiratory tract samples (such as sputum and nasopharyngeal swabs) and digestive tract samples (such as stool and anal swabs), with a sampling interval of at least 24 h."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The intervention measures for discharged COVID-19 cases are as follows: 1) all discharged COVID-19 cases are isolated in designated hotels for another 14 days; 2) during isolation, discharged cases live in a well-ventilated single room, dine separately, practice hand hygiene, and minimize close contact with others, 3) health status is monitored during isolation and SARS-CoV-2 RT-PCR tests are performed on 7th and 14th days after discharge or more frequently, 4) cases return home only when nucleic acid tests are negative on both respiratory tract samples and digestive tract samples during isolation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ARTIC bioinformatics pipeline for COVID (https://artic.network/ncov-2019) was used to generate consensus sequences and call single nucleotide changes relative to the reference sequence (MN908947)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Assembly of the nanopore raw data was performed using the ARTIC bioinformatic pipeline for COVID-19 with minimap2 [11] and medaka (https://github.com/nanoporetech/medaka) for consensus sequence generation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequencing data after mapping to SARS-COV-2 reference genome (",
            "MN908947.3",
            ") have been deposited in the ",
            "Genome Sequence Archive",
            " [12] in ",
            "BIG Data Center",
            " [13], ",
            "Beijing Institute of Genomics (BIG)",
            ", ",
            "Chinese Academy of Sciences",
            ", under project accession numbers ",
            "CRA002500",
            ", publicly accessible at ",
            "https://bigd.big.ac.cn/gsa",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 3026,
                "end": 3036,
                "name": "MN908947.3"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 3065,
                "end": 3088,
                "name": "Genome Sequence Archive"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 3097,
                "end": 3112,
                "name": "BIG Data Center"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 3119,
                "end": 3154,
                "name": "Beijing Institute of Genomics (BIG)"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 3156,
                "end": 3183,
                "name": "Chinese Academy of Sciences"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 3217,
                "end": 3226,
                "name": "CRA002500"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 3251,
                "end": 3277,
                "name": "https://bigd.big.ac.cn/gsa"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T6"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T7"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T4",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "A total of 619 COVID-19 cases were discharged from designated hospitals between 23 January and 19 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The demographic characteristics of the 87 re-positive cases are as follows: (i) gender distribution was equal, with 45 males and 42 females; (ii) re-positive detection of virus RNA was observed in all age groups, ranging from 3 months to 69 years, with a median age of 28 years, which is significantly younger than that of discharged COVID-19 patients in Guangdong in general (median age of 47 years, Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median time for discharged COVID-19 cases re-tested as viral RNA positive was 7 days (range 2 to 19 days) post-discharge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Possibly due to their moderate clinical symptoms, re-positive cases had shorter hospital stays (median, 14 days) than general discharged COVID-19 cases (median, 28 days) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An impaired immune response has been associated with fatal COVID-19 infections that exhibit prolonged persistence of viral RNA [14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One possible explanation for the re-positive detection of SARS-CoV-2 RNA is that some COVID-19 patients may have insufficient immune responses and neutralization antibodies (NAbs) to clear infection completely."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the immunological and virological characteristics of re-positive COVID-19 cases, 70 of 87 re-positive cases were sampled by the Guangdong Provincial Center for Disease Control and Prevention (GDCDC) between 22 February and 1 March 2020, including 59 serum and 137 swab samples (Fig. 1a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results demonstrated competent immune activation in re-positive cases, which exhibit a distribution of NAbs titres similar to that of cases who detected as negative in 14 days after discharge and COVID-19 cases in hospitalization (Kruskal-Wallis H test, p = 0.2663, Fig. 1b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Millions of people have recovered from COVID-19 infection, and there have been preliminary reports of people testing re-positive for SARS-CoV-2 viral RNA after recovery [7, 8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we use data from the Guangdong COVID-19 surveillance system to analyze the characteristics of re-positive cases between 23 January and 26 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first question we addressed is the re-positive rate in COVID-19 discharged cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All re-re-positive cases in our study developed only mild or moderate symptoms in the initial diagnosis, with the median age being significantly lower than that of the general COVID-19 cases (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The relatively mild symptoms may explain why the median time from onset to discharge in re-positive cases (median 17 days) is slightly lower than that of the other discharged COVID-19 cases (median 33 days)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The time from symptom onset to discharge (the time when COVID-19 cases have twice tested negative by PCR) for re-positive cases (median 17, Table 1) is consistent with the time that detectable SARS-CoV-2 RNA is reported on other studies to persist (median 20) in respiratory sites [14,15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data indicate that the course in re-positive cases is similar to other COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our microneutralization result shows that 58 of 59 (98%) re-positive cases generated specific NAbs to SARS-CoV-2, and their titre distribution is similar to cured COVID-19 cases that were SARS-CoV-2 negative after discharge and to hospitalized COVID-19 cases (Fig. 1b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Some COVID-19 cases test positive again for SARS-CoV-2 RNA following negative test results and discharge, raising questions about the meaning of virus detection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Clinical data were obtained through Guangdong's COVID-19 surveillance network."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Findings  Among 619 discharged COVID-19 cases, 87 re-tested as SARS-CoV-2 positive in circumstances of social isolation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Re -positive cases ( n = 59) exhibited similar neutralization antibodies (NAbs) titre distributions to other COVID-19 cases ( n = 218) tested here."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally and cause massive societal disruption and death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of August 3, 2020, COVID-19 has been responsible for >18 million cases and approximately 690,000 deaths worldwide (Johns Hopkins University & Medicine, , last accessed August 3, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The United States is in the midst of a substantial surge of new cases, and despite months of effort, few treatment options with proven efficacy for COVID-19 are available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, hundreds of registered clinical trials are underway, most of which are assessing antiretroviral agents, anti-inflammatory or immunosuppressant therapies, and passive antibody treatments.1, 2, 3 The antiretroviral remdesivir, an RNA polymerase inhibitor with activity against SARS-associated coronavirus and Middle East respiratory syndrome coronavirus, has shown promise in a recent randomized controlled trial, reducing recovery time in certain COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many vaccines are in various stages of development, and one is being studied in a phase 3 trial, but it will be at least many months before an efficacious vaccine is available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Thus, although many prophylactic and therapeutic strategies are under investigation, the primary management of COVID-19 remains supportive care."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Food and Drug Administration rapidly made pathways available for the administration or study of COVID-19 convalescent plasma, and convalescent plasma remains the only widely available passive antibody therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar safety findings have been shown in other studies.18, 19, 20, 21, 22, 23",
            "We recently published our early experience with convalescent plasma treatment in 25 patients with severe COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients admitted to any of the eight Houston Methodist hospitals were considered for enrollment in this trial."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Patients were eligible for this study if they had severe and/or life-threatening COVID-19 (US Food and Drug Administration, , last accessed July 11, 2020)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "US Food and Drug Administration recommendations for COVID-19 convalescent plasma donor collection were followed (, last accessed July 11, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All plasma was donated by recovered and healthy COVID-19 patients who had been asymptomatic for >14 days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Convalescent plasma titer assessment was performed as recently described."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Briefly, purified recombinant ectodomain, composed of amino acid residues 1 to 1208, and/or RBD, composed of amino acids 319 to 591, of the SARS-CoV-2 spike protein (; ",
            "GenBank",
            " accession number ",
            "MN908947",
            ") were coated onto microtiter plates."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2533,
                "end": 2540,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2558,
                "end": 2566,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Baseline patient characteristics for all COVID-19 patients and for patients who met a 28-day outcome are shown in Supplemental Table S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A titer of ≥1:1350 was chosen on the basis of previous work that demonstrated that an anti-RBD IgG 1:1350 indicated an 80% probability of viral neutralization titer ≥1:160, the recommended viral neutralization cutoff for COVID-19 convalescent plasma for therapeutic purposes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, data from 2724 admitted COVID-19 patients were available for analysis, 316 of whom were transfused with COVID-19 convalescent plasma (Figure 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Baseline characteristics of all admitted COVID-19 patients are shown (Supplemental Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most transfused patients (242/316; 76%) received only one unit of COVID-19 convalescent plasma."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a smaller study by Hegerova et al, 20 COVID-19 patients who received convalescent plasma had improved laboratory and respiratory parameters compared with matched controls, and in both matched control studies, nonintubated patients benefited more from transfusion than intubated patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data from 20,000 transfused COVID-19 patients support the notion that transfusion earlier in the clinical course is more beneficial."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent study from the Netherlands showed that at the time of transfusion (median, 10 days post-symptom onset), many (80%) of the COVID-19 patients already had detectable neutralizing antibody titers, although the titer of transfused plasma units was higher than that found in recipients; the study was discontinued as a result of this finding."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This analysis has implications for collection, use, and study of COVID-19 convalescent plasma."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Substantial efforts are underway in the United States to collect COVID-19 convalescent plasma."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical trials are ongoing in many centers, and the data presented herein may inform the assessment of equipoise in their design and conduct.39, 40, 41, 42",
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and proven treatments are limited."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 is among many approaches being studied as potentially efficacious therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We are conducting a prospective, propensity score–matched study assessing the efficacy of COVID-19 convalescent plasma transfusion versus standard of care as treatment for severe and/or critical COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 316 transfused patients, 136 met a 28-day outcome and were matched to 251 non-transfused control COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that treatment of COVID-19 with high anti–receptor binding domain IgG titer convalescent plasma is efficacious in early-disease patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Staff shortages in health care are significant amidst the global effort against coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of asymptomatic cases of COVID-19 is significant."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a study of COVID-19 symptomatic and asymptomatic infection on the Diamond Princess cruise ship, 328 of the 634 positive cases (51·7%) were asymptomatic at the time of testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, evidence from modelled COVID-19 infectiousness profiles suggests that 44% of secondary cases were infected during the presymptomatic phase of illnesses from index cases, whereas a study of COVID-19 cases in a homeless shelter in Boston, MA, USA, implies that individual COVID-19 symptoms might be uncommon and proposed universal testing irrespective of symptomatic burden."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Substantial asymptomatic transmission might also mean that current estimates of the basic reproduction number, R0, for COVID-19 are inaccurate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This disease spread could, in turn, propagate out of hospitals: during a period of lockdown asymptomatic COVID-19 carriage among hospital staff could conceivably act as a potent source of ongoing transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The scale of this problem is not yet fully understood, nor is the full potential for asymptomatic and presymptomatic HCWs to transmit infection to patients who do not have COVID-19, other HCWs, or the public."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In partnership with the Francis Crick Institute in London, UK, where COVID-19 testing will be performed, this initiative is an attempt to further limit nosocomial transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A healthy, COVID-19-free workforce that is not burned out will be an asset to the prolonged response to the COVID-19 crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This approach could mean that presymptomatic HCWs who are capable of transmitting the virus are not being tested; if they were tested and found to be COVID-19 positive, they could be advised to isolate and await the onset of symptoms or, if no symptoms develop, undergo repeat testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Diamond Princess cruise ship was the site of a large outbreak of coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Afterwards, the disease was named “Coronavirus Disease 2019 (COVID-19)” by the World Health Organization (WHO) [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GnomAD",
            " database analysis revealed that these identified ACE2 variants are reported with a cumulative frequency of 0.2289 in ethnically matched populations (EUR)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 116,
                "end": 122,
                "name": "GnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this variant deserves further investigation in a larger COVID-19 cohorts as well as functional studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The missense variant c.2158A>G p.(Asn720Asp) was found in two patients, one female in heterozygous state and one male, with a frequency in line with our Italian control population and with the frequency reported for the European non-Finnish population in the ",
            "GnomAD",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 650,
                "end": 656,
                "name": "GnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We tested the hypothesis if these variants were associated with COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this reason, we wanted to analyze in detail the genetic variability of ACE2 in our population, among the most affected by the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Until now, most available published studies were carried out on an epidemiological basis of population allele frequencies deposited in the various available databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified in a single COVID-19 patient a variant (p.Asp630His), very rare in European population and not detected in our Italian control population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly very recently, Bunyavanich et al. [19] showed age-dependent expression of ACE2 gene in nasal epithelium, highlighting that the different levels of ACE2 expression may be the reason for a lower incidence of COVID-19 in children."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Animal coronaviruses rarely infect humans with the exceptions of the Middle East respiratory syndrome ( MERS-CoV ), the severe acute respiratory syndrome corona virus (SARS-CoV), and now SARS-CoV-2, which is the cause of the ongoing pandemic of coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We therefore investigated the occurrence of ACE2 variants in a cohort of 131 Italian unrelated individuals clinically diagnosed with COVID-19 and in an Italian control population, to evaluate a possible allelic association with COVID-19, by direct DNA analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a pilot study, we analyzed, by whole-exome sequencing, genetic variants of ACE2 gene in 131 DNA samples of COVID-19 patients hospitalized at Tor Vergata University Hospital and at Bambino Gesù Children’s Hospital, Rome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, further studies are needed in larger cohorts, since it was found only in one heterozygous COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results suggest that there is no strong evidence, in our cohort, of consistent association of ACE2 variants with COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to Centers for Disease Control and Prevention (CDC), common human infecting coronaviruses include 229E coronavirus, NL63 coronavirus, OC43 beta coronavirus, HKU1 coronavirus, MERS-CoV, SARS-CoV, and the recently emerged deadly coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, COVID-19 was initially encountered in Wuhan, China, and has now rapidly spread to multiple countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Outbreaks of infectious disease like COVID-19 poses a serious challenge to the scientific community since they usually arise from unrecognized zoonotic sources or due to scarcity data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current study focuses on finding promiscuous CD4+ and CD8 T+ cell epitopes for chimeric COVID-19 vaccine development using a variety of web-based tools."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "Immune epitope database (IEDB)",
            " tool for immunogenicity score calculation was used to predict immunogenicity scores for all MHC-I predicted epitopes (27)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 740,
                "end": 770,
                "name": "Immune epitope database (IEDB)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immunogenic epitopes were then verified for their presence in ",
            "IEDB",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 956,
                "end": 960,
                "name": "IEDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PDBsum is a database that is exclusively designed to show the molecules that build DNA or proteins, ligands, and metal ions along with the illustration of graphical representation of their interactions with each other."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prioritized vaccine constructs were docked to ACE2 receptor (",
            "PDB",
            " ID: ",
            "3sci",
            "), TLR2 (",
            "PDB",
            " ID: ",
            "2Z7X",
            "), and TLR4 (",
            "PDB",
            " ID: ",
            "4G8A",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1251,
                "end": 1254,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1259,
                "end": 1263,
                "name": "3sci"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1272,
                "end": 1275,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1280,
                "end": 1284,
                "name": "2Z7X"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1297,
                "end": 1300,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1305,
                "end": 1309,
                "name": "4G8A"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Vaccine 3, having a B-cell epitope, was also checked for its interaction with a B-cell receptor (BCR) CD79 (",
            "PDB",
            " ID: ",
            "3KG5",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1420,
                "end": 1423,
                "name": "PDB"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1428,
                "end": 1432,
                "name": "3KG5"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "Hence, for this purpose, class I [HLA A*02 01 (",
            "PDB",
            " ID ",
            "4U6Y",
            "), HLA B*51 01 (",
            "PDB",
            " ID ",
            "4MJI",
            ")] and class II [HLA-DRB1*1402 (",
            "PDB",
            " ID ",
            "6ATF",
            ")] were used; they represent broad-spectrum peptide-binding repertoires."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1482,
                "end": 1485,
                "name": "PDB"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1489,
                "end": 1493,
                "name": "4U6Y"
            },
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1509,
                "end": 1512,
                "name": "PDB"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1516,
                "end": 1520,
                "name": "4MJI"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 1552,
                "end": 1555,
                "name": "PDB"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 1559,
                "end": 1563,
                "name": "6ATF"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T11",
                "end": "T12"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T13",
                "end": "T14"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T15",
                "end": "T16"
            }
        ]
    },
    {
        "sen": [
            "Initially, 15,181 HLA class I epitopes have been predicted within spike glycoprotein of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two epitopes 191EFVFKNIDGYFKIYS205 and 506QPYRVVVLSFELLHA520 were selected for vaccine 1 construction on the basis of their high antigenic potential."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, none of the epitopes reported in this study have been previously added to the ",
            "IEDB",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 1992,
                "end": 1996,
                "name": "IEDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, there is currently no available FDA-approved vaccine against COVID-19 (42, 43)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A vaccination regime, if successfully developed against COVID-19, has the ability to improve global human health statistics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, it might take months to years to actually derive a vaccine against COVID-19, we believe that our contribution in this case might be a useful to initiate the process."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent studies have strongly suggested that COVID-19 uses angiotensin-converting enzyme 2 (ACE2) as its potential receptor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several critical residues in COVID-19 receptor binding motif (RBM) of S1 domain particularly Gln493 provide favorable interactions with human ACE2 (53)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vaccines designed in this study may also interact with ACE2 resulting interrupted interaction of the receptor with the viral spike protein and thus can be a potential therapeutic target against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All datasets presented in this study are included in the article/Supplementary Material."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent pandemic caused by a single-stranded RNA virus, COVID-19, initially discovered in China, is now spreading globally."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We adapted a comprehensive predictive framework to provide novel insights into immunogenic epitopes of spike proteins, which can further be evaluated as potential vaccine candidates against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In late 2019, an outbreak of the novel ​Severe acute respiratory syndrome-related coronavirus SARS-CoV-2, the causative agent of COVID-19, began in Wuhan, China and rapidly spread throughout the world (Zhou et al., 2020; Zhu et al., 2020; Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the data shared by World Health Organization (WHO), as of June 25th, over nine million people have tested positive for COVID-19, with a mortality of over 480,000 people worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, early virus detection and isolation of COVID-19 ‘positive’ individuals are crucial to limit virus transmission and implementation of effective measures to control the spread of the virus and relieve the burden on the healthcare system (Jones et al., 2014; Isere et al., 2015)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, these methods have some drawbacks, including low specificity, a high rate of false positives, and difficulty of adapting these techniques for effective POC diagnostics for pandemics such as COVID-19 (Chou et al., 2011; Nagai et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The positive samples had different Ct values ranging from 15 to 40 with the CDC qPCR N gene primer sets (IDT, Catalogue #10,006,606)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Various detection modules, including GeneXpert, Cephied, and ID NOW by Abbot are low throughput and require the use of a single machine for each sample, which may be impractical for low-resource environments and where large-scale testing in a short time window is needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lateral flow cleavage reporter (​5′-​/56-FAM/TTATTATT/3Bio/​-3′​, IDT) was added to the reaction at a final concentration of 500 nM in 100 μL reaction volume along with the 2 μL RT-LAMP product, and the reaction was incubated at 37 °C (62 °C for Cas12b) for 10–30 minutes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The initial 50 μL of reaction mix contains the complete RT-LAMP reagents such as 5 μL 10X isothermal amplification buffer, 5 μL 10X Primer Mix, 4 μL of 100 mM MgSO4, 7 μL of 10 mM dNTP mix, 2 μL of Bst LF DNA polymerase (50 ng), and 2 μL of RTx reverse transciptase 4 ng/μl, together with 2.5 μL of 500 ng/μL salmon sperm DNA, 2 μL of viral (control or clinical sample) RNA, 5 μL of 5 μM specific (or non-specific) AacCas21b sgRNAs and 5 μL of 5 μM lateral flow cleavage reporter (​5′-​/56-FAM/TTATTATT/3Bio/​-3′​, IDT) and 5.5 μL nuclease-free water."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic caused by SARS-CoV-2 affects all aspects of human life."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our iSCAN SARS-CoV-2 detection module, which exhibits the critical features of a robust molecular diagnostic device, should facilitate the effective management and control of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We read with great interest the review by Khan et al",
            " who discussed the emerging role of cardiovascular disease and the progression of the novel coronavirus disease 19 (COVID‐19)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We commend their conclusions that appropriate triage and risk stratification is essential in patients with cardiovascular disease (CVD) and COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RAAS inhibitors contributing to increased severity of COVID‐19, most commonly in hypertension, is a logical hypothesis due to their mode of action."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early observational studies concluded that the use of RAAS inhibitors may not be associated with SARS‐CoV‐2 infection or more severe COVID‐19 progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One retrospective multicentre study with 1128 participants (188 on a RAAS inhibitor) suggested that in hospitalized COVID‐19 patients with pre‐existing hypertension, RAAS inhibitors had better outcomes compared to non‐RAAS inhibitor use."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is pivotal further preclinical studies are carried out to understand the cardiovascular mechanisms in COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is already clear that maintaining services as usual during the COVID‐19 pandemic is, in many settings, no longer possible."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Colleagues in charge of services in the main childhood cancer center serving the Lombardy region, Northern Italy, have provided highly practical information on how they have managed to deliver usual anticancer care while minimizing transmission of COVID‐19 (Supplement II)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The crucial factors for managing the overwhelming service demand included: (1) clear clinical leadership; (2) a dynamic standard operating procedure for the service; (3) SARS‐CoV‐2 viral testing of all staff and all patients prior to any elective procedures or admission; (4) professional monitoring of handwashing and the use of appropriate personal protective equipment (PPE) by staff and families on entering and leaving clinical areas; (5) restricting accompanying persons to one per patient; (6) “cohorting” of staff for work and rest periods; (7) physical separation of oncology staff from staff working in COVID‐19 areas; and (8) elective reduction of high‐risk procedures (CAR‐T and stem cell therapies) to reduce the demand for intensive care services."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The emerging experience from regions with high community transmission SARS‐CoV‐2 suggests that an age‐related pattern of upper and lower respiratory tract syndromes of mild to moderate severity is the most common presentation of COVID‐19 in children, but with some reports of a very severe clinical disease with life‐threatening respiratory failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            ", ",
            " COVID‐19 may also rarely manifest as a true systemic disease, including myocarditis, meningo‐encephalitis, macrophage activation syndrome, and thromboembolic phenomena."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of manuscript preparation, data on the clinical spectrum and outcome of children with cancer and concurrent COVID‐19 are limited, and further data are awaited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, other coronaviruses can produce more severe disease in immunocompromised children with increased risk with coexisting pulmonary disease or concurrent lower respiratory tract infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Although this is not yet proven for SARS‐CoV‐2/COVID‐19, prolonged viral shedding (≥ 21 days) has been documented in hematopoietic stem cell transplant (HSCT) recipients for other human coronaviruses, particularly in the setting of steroid use, and myeloablative conditioning."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ALL is the most common single childhood cancer, with the longest duration of treatment; hence, many cancer services will experience some COVID‐19–related disruption to the care of children with ALL during the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Few COVID‐19–positive ALL cases have been reported so far, and the clinical course of those that have been described is of a mild to moderately severe respiratory syndrome, although anecdotal reports of severe infections and fatal outcomes are emerging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Thus, the major threat to children with ALL may be COVID‐19–related interruption of treatment, or in some settings, treatment noncompletion."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Children with concurrent COVID‐19 and hyperleukocytosis should commence immediate treatment with supportive care and a steroid prophase, and commence disease‐directed therapy on recovery from COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We do not recommend any elective modification of maintenance chemotherapy, but in high COVID‐19 prevalence regions, clinic visits should be minimized by extended dispensing of maintenance chemotherapy supported by virtual contact for clinical review."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Supplement I, Table 1, we provide guidance for adapting patient care if the COVID‐19 pandemic disrupts access to diagnostic investigations and the supply of essential cancer chemotherapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At diagnosis in fully resourced and HIC settings with an emergency presentation, no pandemic modifications are recommended for the initial assessment and diagnosis, even if a child presents with concurrent COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐19 pandemic may compromise the availability and access to the SOC investigations for a complete diagnosis, staging, and response evaluation for risk‐based therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During this COVID‐19 pandemic, elements of these approaches may not be practical or possible, and there will likely be disruption to the timing of planned surgery and radiotherapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may not be the case in countries with limited resources or in areas where access to operating theater and ICU is affected by the COVID‐19 situation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐19 pandemic will have a direct impact on radiotherapy resources, and all radiotherapy centers should have a contingency plan in place to deal with revised staffing and workflows at short notice",
            ", ",
            ", ",
            ", ",
            ", ",
            ", ",
            ", ",
            " and Supplement II."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Exposed team members are required to adhere to consensus guidelines, use airborne precaution PPE (e.g., N95 mask with face shield), and care for patients with suspected or confirmed COVID‐19 cases in designated operative and perioperative area."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Children with high‐risk cancers represent a particularly vulnerable population during this COVID‐19 pandemic, especially when it comes to palliative care needs."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These children are at increased risk for symptom‐related distress as well as psychological and emotional trauma as a result of the COVID‐19 crisis in addition to their already incredibly distress‐inducing cancer diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 is leading to a surge in demand for healthcare services, including shifting resources and requiring uncomfortable conversations about resource allocation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The potential role and response of palliative care and hospice services in this COVID‐19 pandemic are demonstrated in Supplement II and Supporting Information Table S9."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nurses are on the frontlines of treating and preventing the spread of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospital leaders should provide written, evidence‐based recommendations for infection prevention and control practices during the COVID‐19 crisis, including guidelines for hand hygiene, use of PPE, staff and visitor screening, isolation of symptomatic patients, and environmental disinfection protocols."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nursing shortages due to COVID‐19 or other illnesses challenge appropriate care even in HIC,",
            " but threaten basic oncology care in LMICs."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospitals need rigorous policies and procedures for the screening, isolation, and care of patients and families at risk of or infected with COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospital cleaners must be trained and supervised in disinfecting patient care areas and equipment, and nursing staff must take particular care in handling patient excreta, soiled bedlinen etc. from patients with confirmed or suspected COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar stringent precautions are required to protect the pediatric oncology clinical area and reduce transmission risks of COVID‐19 among its patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Lombardy experience recommends the use of masks for all staff in pediatric oncology for all clinical encounters, with surgical masks for non COVID‐19 contact, reserving N95 masks for high‐risk clinical encounters such as aerosol‐generating procedures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Advice on the use of PPE during the COVID‐19 pandemic is evolving and differs between countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Food and Drug Administration,",
            " the National Cancer Institute's Cancer Therapy Evaluation Program,",
            " and the European Medicines Agency",
            " have provided recommendations on conducting research during the COVID‐19 pandemic."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The principles of these recommendations are captured in guidances provided by the COG and the European Society of Paediatric Oncology (SIOP‐E) including provision for telemedicine evaluations in place of clinical visits, remote dispensing of oral investigational agents, and acknowledging minor protocol deviations to reduce the risk of COVID‐19 spread among patients and medical providers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is a paucity of data on the clinical manifestations and outcome of COVID‐19 in children being treated for or having recently completed cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the rarity and spectrum of childhood cancers, it is unlikely that any single center will see more than a few sporadic cases of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To address the need for well‐curated clinical data, ",
            "St Jude Global",
            " and ",
            "SIOP",
            " have created a global ",
            "COVID‐19 childhood cancer registry",
            " to learn more about the impact of the virus on childhood cancer patients worldwide and for us all to be better prepared to meet future similar challenges,",
            " ",
            "St Jude Global",
            " and ",
            "SIOP",
            " have put out a call for clinicians worldwide to voluntarily report any patient with a malignancy or prior hematopoietic stem cell transplant who is under the age of 19 at the time of a laboratory confirmed SARS‐CoV‐2 infection."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 7920,
                "end": 7934,
                "name": "St Jude Global"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 7939,
                "end": 7943,
                "name": "SIOP"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 7966,
                "end": 8000,
                "name": "COVID‐19 childhood cancer registry"
            },
            false,
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 8157,
                "end": 8171,
                "name": "St Jude Global"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 8176,
                "end": 8180,
                "name": "SIOP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, to work with their public health colleagues to send a clear message to parents and communities, fear of COVID‐19 infection should not prevent seeking medical assessment if they have serious concerns about their child's health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A full understanding of who is at risk of developing serious COVID‐19 disease and how to prevent and treat this can only come from a global effort to capture detailed prospective data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More worrying is the potential for children with cancer to become indirect victims of the COVID‐19 pandemic, due to late diagnosis and disrupted therapies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS‐CoV‐2 (COVID‐19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Functional annotation of human genes was accomplished on the DAVID website (Jiao et al. 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The overlapping between the top 1000 genes in the two datasets > 86% (Fig. 3b), so in the following analyses we combined ",
            "GSM1120308",
            " and ",
            "GSE93482",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 216,
                "end": 226,
                "name": "GSM1120308"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 231,
                "end": 239,
                "name": "GSE93482"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The RNA-seq data used in this study were downloaded with accession numbers ",
            "GSM1120308",
            " (polyA RNA sequencing of STL001 Lung Cells) and ",
            "GSE93482",
            " (polyA mRNA RNA-seq from lung)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 316,
                "end": 326,
                "name": "GSM1120308"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 375,
                "end": 383,
                "name": "GSE93482"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 outbreak caused by SARS-CoV-2 infection (Lu et al., 2020, Ren et al., 2020, Zhou et al., 2020, Zhu et al., 2020) has been declared as a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Typical clinical symptoms of COVID-19 are fever, cough, myalgia, and shortness of breath (Huang et al., 2020, Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, no specific antiviral treatment is available for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical study on COVID-19 has suggested the hypercytokinemia in severe cases (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we collected the bronchoalveolar lavage fluid (BALF) of eight COVID-19 patients, 146 community-acquired pneumonia patients, and 20 healthy controls; this is followed by metatranscriptome sequencing and functional analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "BALFs were obtained from laboratory-confirmed COVID-19 patients (SARS2) (n = 8), community-acquired pneumonia patients (CAP) (n = 146), and healthy controls without known respiratory diseases (Healthy) (n = 20)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The read counts for SARS-CoV-2 in each COVID-19 case were listed in Table S2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, our global functional analysis revealed a highly responsive state against noxious stimuli in COVID-19 cases, characterized by the potent defense responses and hyperactive ribosome biogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand the cytokine profile in BALF from the COVID-19 patients, we assigned DEGs into seven categories of cytokine-related genes (Figure 2",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These observations suggested that the exuberant inflammation in COVID-19 could be progressively resolved, and unquenched inflammation may result in detrimental outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CXCL17 upregulation is specific to SARS2 and was observed in all eight cases (Figure 2B), suggesting a role of CXCL17 in COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IL1RN and ILB are interleukin genes significantly upregulated in SARS2 (Figure 2B), and these upregulations are mirrored by elevated protein levels of IL-1Ra and IL-1β in plasma of COVID-19 patients (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because IL-1β was recognized as the key cytokine driving proinflammatory response in BALF from patients with ARDS (Pugin et al., 1996), it is possible that the ratio of IL-1β to its inhibitor, IL-1Ra, may correlate to inflammation intensity in COVID-19 patients; however, we did not observe clear correlation in the current study (Figure 2B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then examined the IFN response in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results pointed to the immunopathological role of IFN response in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent study suggested that the neutrophil-to-lymphocyte (NLR) ratio was associated with the disease severity of COVID-19 (Liu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis also showed a significantly higher NLR in COVID-19 cases (Figure S3A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the current study, we sampled COVID-19 patients with bronchoalveolar lavage (BAL), a method for retrieving cells and solutes from different areas of the lung (Meyer et al., 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By sequencing and analyzing the BAL fluid cells from eight COVID-19 patients and control cohorts, we obtained gene expression profiles of both host and virus, which directly reflected the in situ host response against SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We thus provided a valuable opportunity to garner insights into COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19 patients, we observed the upregulation of a plethora of proinflammatory cytokines, suggesting the pathogenic role of hypercytokinemia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, our data unraveled a possible chemokine-dominant hyperactive cytokine response in COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This protective potential of ISGs may account for the lower proportion of severe cases and the case-fatality rate in COVID-19 as compared to SARS (Wu and McGoogan, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the ISGs identified in COVID-19 cases, we found a subset of genes with proinflammatory activities, which is relatively underrepresented in other viral infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The accession number for the reads mapped to human genome GRCh38 extracted from the raw sequencing data reported in this paper is [",
            "Genome Warehouse in National Genomics Data Center",
            " (National Genomics Data Center Members and Partners, 2020)]: [",
            "PRJCA002273",
            "] that is publicly accessible at ",
            "https://bigd.big.ac.cn/gsa",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 3816,
                "end": 3865,
                "name": "Genome Warehouse in National Genomics Data Center"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 3928,
                "end": 3939,
                "name": "PRJCA002273"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 3972,
                "end": 3998,
                "name": "https://bigd.big.ac.cn/gsa"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "BALF samples from eight laboratory-confirmed COVID-19 patients (SARS2) were collected from hospitals in Wuhan in January 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data collection for the COVID-19 patients were deemed by the National Health Commission of the People’s Republic of China as the contents of the public health outbreak investigation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the COVID-19 cases, five were male and three were female."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eight COVID-19 cases had an average age of 49 years (range 40-61), and 112 CAP cases had an average of 56.4 years (range 22-91)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection have posed a severe threat to global public health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we used metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of eight COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Highlights     •  BALF cell transcriptome indicates robust innate immune responses in COVID-19 patients    •  COVID-19 patients exhibit chemokine-dominant hypercytokinemia    •  ISGs are highly expressed in COVID-19 patients and exhibit pathogenic potential      Zhou et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "use metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients exhibit robust innate immune responses with notable hypercytokinemia and increased expression of IFN-stimulated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This analysis provides timely information for understanding SARS-CoV-2-host interactions and COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On these grounds, there is an aspiration to generate new diagnostic tests that combine speed (incorporating the potential for POCT [18, 19]), sensitivity, detection of coinfection (20, 21), and generation of quantitative or semiquantitative data that can be used to identify drug resistance and reconstruct phylogeny to inform surveillance, public health strategy, and vaccine design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reads were first taxonomically classified against the ",
            "RefSeq",
            " database using Centrifuge v1.0.3 (31)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 443,
                "end": 449,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resulting draft consensus sequences were subjected to a BLAST search against an influenza virus sequence database that included >2,000 H1N1 and H3N2 seasonal influenza virus sequences between 2018 and 2019 and were downloaded from the ",
            "Influenza Research Database",
            " (33)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 728,
                "end": 755,
                "name": "Influenza Research Database"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this small data set, sensitivity is 83% and specificity is 100% (95% CI, 67 to 93% and 69 to 100%, respectively)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Infectious Diseases Society of America (IDSA) guidelines (9) recommend nasal/nasopharyngeal specimens for influenza diagnosis, but throat swabs are easier to collect in clinical practice and therefore account for the majority of diagnostic samples processed by our clinical microbiology laboratory."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our test set, 8% of samples showed insufficient sensitivity for Hazara virus; however, half of these contained a high titer of influenza virus, so only 4% were true sensitivity failures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Assessment of diversity within deep-sequence data sets provides an opportunity to investigate the relationship between within-host polymorphisms and clinical outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Larger and more diverse data sets will be required to set more rigorous thresholds for base calling."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus titers in culture supernatants of the five cases at 3 d p.i. were 4.6 × 106 to 6.8 × 107 median tissue culture infectious dose (TCID50) per mL (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next-generation sequencing (NGS) of case Wk-521 detected the nearly full-length genome sequence from SARS-CoV-2 with >99.9% homology (1, 2) (",
            "GISAID",
            " database ID ",
            "EPI_ISL_408667",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 305,
                "end": 311,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 324,
                "end": 338,
                "name": "EPI_ISL_408667"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "All sequences are amplified, followed by classification of sequences based on a reference database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, detection and identification of novel, previously unknown emerging viruses presents a challenge due to the absence of their genome sequences in reference databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Identification of coronaviruses was tested using modified databases lacking SARS-CoV-2, SARS-CoV, and MERS-CoV, mimicking the situation at the time of virus discovery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After quality pre-processing using an in-house QC pipeline, Biopet version 0.9.0 [17] and removal of human reads after mapping them to human reference genome GRCh38 [18] with Bowtie2 version 2.3.4 [19], the remaining sequencing reads were taxonomically classified using Centrifuge 1.0.2-beta [20] with the databases prepared by taking all 12,302 ",
            "Refseq",
            " viral genomes (as of Juny 16th, 2020) and extracting the ",
            "GenBank",
            " records annotated before the dates of the existence of the MERS-CoV and SARS-CoV index patients in 2012 and 2002, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 788,
                "end": 794,
                "name": "Refseq"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 852,
                "end": 859,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All contigs were analyzed using the ",
            "NCBI",
            " Basic Local Alignment Search Tool (BLAST 2.8.1) [23] using the BLAST ",
            "NCBI’s nucleotide (nt)",
            " database (accessed April 2018)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1024,
                "end": 1028,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1098,
                "end": 1120,
                "name": "NCBI’s nucleotide (nt)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After extraction of human reads, FASTQ files generated for SARS-CoV-2 samples (with and without viral enrichment) were uploaded for classification and de novo assembly by the commercial web-based tool Genome Detective v1.120 (www.genomedetective.com, accessed 2020-05-11) [9], using a reference database (generated 2019-09-21)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In brief, after removal of low-quality reads and trimming by Trimmomatic [24], candidate viral reads were identified using the protein-based alignment method DIAMOND [25] in combination with the ",
            "Swissprot UniRef",
            "90 protein database followed by de novo assembly using metaSPAdes [26]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1676,
                "end": 1692,
                "name": "Swissprot UniRef"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Blastx and Blastn [23] were used to search for candidate reference sequences using the ",
            "NCBI",
            " ",
            "RefSeq",
            " virus database (accessed 2019-09-21)."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1851,
                "end": 1855,
                "name": "NCBI"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1856,
                "end": 1862,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To mimic the classification conditions present in the setting of virus discovery, viral metagenomic reference genome databases created before the emergence of SARS-CoV-2, SARS-CoV and MERS-CoV were used for the classification of sequence reads (December 2019 for the two SARS-CoV-2 positive samples, November 2002 for the SARS-CoV and June 2012 for the MERS-CoV positive samples)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GenomeDetective results of identification of SARS-CoV-2 sequences using a database created before the emergence of SARS-CoV-2 are shown in Fig. 2",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we evaluated the performance of a metagenomic sequencing protocol for the identification of emerging viruses using clinical samples in combination with a simulated reference database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The performance of a viral metagenomic protocol in a clinical setting for the identification of novel coronaviruses was tested using clinical samples containing SARS-CoV-2, SARS-CoV, and MERS-CoV, in combination with databases generated to contain only viruses of before the discovery dates of these coronaviruses, to mimic virus discovery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, Ji et al. [10] recommended best practices for processing HIV NGS data, which include reference-based assembly using Bowtie2 [11] as the short read aligner and HXB2 (",
            "NCBI",
            " accession: ",
            "K03455",
            "; [12]) as the reference sequence for constructing a consensus sequence."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 175,
                "end": 179,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 191,
                "end": 197,
                "name": "K03455"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For the purposes of this study, we focus on the composition of the consensus sequences, but additionally report haplotype data for the HIV and HCV empirical datasets as validation of HAPHPIPE’s intra-host analytical capabilities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Below, we introduce the three tools that were used in generating consensus sequences, as well as the simulated and empirical datasets used in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, the default parameters included: a minimum of 20% frequency for a base to be included in the consensus sequence, the default mutation database—which is the Stanford SDRM 2009 list of mutations—a target coverage of 10,000 reads, a minimum read length of 100 bp, a minimum average read quality score of 30, a sequencing platform error rate of 0.0021, a minimum variant quality of 30, a minimum read depth of 100 for a variant call, a minimum allele count of five to be considered a variant, and a minimum amino acid frequency of 0.01 for a mutation to be considered in the drug-resistant report."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These reads were also error-prone, implemented with the integrated Illumina MiSeq platform error profile, which means that the reads contained errors known to be caused by the sequencing platform itself, creating a realistic representation of a standard NGS dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All ",
            "SRA",
            " accessions, each representing empirical HIV-1 NGS amplicon data from two populations sampled repeatedly over one year, were selected from the BioProject accession ",
            "PRJNA506879",
            " [63]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1528,
                "end": 1531,
                "name": "SRA"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1695,
                "end": 1706,
                "name": "PRJNA506879"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "A total of 23 ",
            "SRA",
            " accessions of HCV sequence data were selected from ",
            "Babcock et al.",
            " [64] (accession numbers: ",
            "SRR1170557",
            ", ",
            "SRR1170560",
            "-",
            "SRR1170568",
            ", ",
            "SRR1170576",
            "-",
            "SRR1170579",
            ", ",
            "SRR1170671",
            "-",
            "SRR1170679",
            "), each representing HCV viral variants from a patient cohort at several time points spanning two months."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1727,
                "end": 1730,
                "name": "SRA"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1782,
                "end": 1796,
                "name": "Babcock et al."
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1822,
                "end": 1832,
                "name": "SRR1170557"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1834,
                "end": 1844,
                "name": "SRR1170560"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1845,
                "end": 1855,
                "name": "SRR1170568"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1857,
                "end": 1867,
                "name": "SRR1170576"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1868,
                "end": 1878,
                "name": "SRR1170579"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1880,
                "end": 1890,
                "name": "SRR1170671"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1891,
                "end": 1901,
                "name": "SRR1170679"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T7"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T8"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T5",
                "end": "T9"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T5",
                "end": "T10"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T5",
                "end": "T11"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T5",
                "end": "T12"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T5",
                "end": "T13"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T6",
                "end": "T8"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T6",
                "end": "T9"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T6",
                "end": "T10"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T6",
                "end": "T11"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T6",
                "end": "T12"
            },
            {
                "id": "R16",
                "bool": true,
                "head": "T6",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "For reference-based pipelines, we used the H77 HCV reference sequence (accession: ",
            "NC_004102",
            "), which is of HCV subtype 1a [150]."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 2089,
                "end": 2098,
                "name": "NC_004102"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also reconstructed haplotypes for this dataset, estimated genetic diversity for consensus sequences from each pipeline, and calculated the corresponding genetic distances (p-distance and adjusted p-distance) between each of the resulting pipeline consensus sequences and H77."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of this study, four high-quality SARS-CoV-2 SRA samples were available (accession numbers: ",
            "SRR11140744",
            ", ",
            "SRR11140746",
            ", ",
            "SRR11140748",
            ", ",
            "SRR11140750",
            "), and we analyzed each through both HAPHPIPE pipelines and Geneious workflows."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 2517,
                "end": 2528,
                "name": "SRR11140744"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 2530,
                "end": 2541,
                "name": "SRR11140746"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 2543,
                "end": 2554,
                "name": "SRR11140748"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 2556,
                "end": 2567,
                "name": "SRR11140750"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used the severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1 (accession ",
            "NC_045512",
            ") as the reference sequence [151]."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 2737,
                "end": 2746,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sought to test whole genome assembly, so the entire genome was used (i.e., no amplicons were assembled for this dataset); this meant that, for the de novo assembly pipeline for HAPHPIPE (haphpipe_assemble_01), we used the numbering 0 to 29,902 for the reference GTF file."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Again, we analyzed assembly statistics, genetic distance from reference metrics, and diversity estimates, as with the previously described datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Median distance to HXB2 was notably greater than distance to the true sequence in all genes for gp120 sequences in the simulation dataset (Figure 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consensus sequences produced for each gene in the empirical HIV dataset showed significant differences in genetic distance to the HIV subtype B reference sequence, HXB2 (p < 0.001; Table A7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, diversity estimates for Geneious de novo sequences were higher than the other constructed consensus sequences, which could be related to the extreme subsampling for this dataset (Table 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was no significant difference in genetic distance for the simulated HIV datasets between the HAPHPIPE pipelines, except for the gp120 amplicon, in which de novo assembly constructed a consensus sequence genetically closer to the true sequence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, for more advanced users and those analyzing large-scale datasets, this becomes a hindrance to efficiency."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, storing large-scale NGS datasets locally on the user’s computer as opposed to remotely on a high-performance cluster, may pose limitations for larger studies in using GUIs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We validate and compare the consensus sequence assembly methods of HAPHPIPE to those of two alternative software packages, HyDRA and Geneious, using simulated HIV and empirical HIV, HCV, and SARS-CoV-2 datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, using empirical data from multiple viruses, we demonstrate that HAPHPIPE can analyze larger sequence datasets due to its greater computational speed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A key dataset in the paper is that 44% of the patients were virus positive, as contrasted with an overall rate of 18% in the state of Massachusetts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The central point to keep in mind, as exemplified by Murphy and colleagues, is that basic science ingenuity and innovation can rapidly be advanced to the actual world of healthcare practice during the current pandemic of COVID-19, but also for other pandemics arising in the future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this issue of Med , Vanuytsel and colleagues 1 demonstrate how academic institutions are stepping up to the forefront of SARS-CoV-2 testing by rapidly implementing a COVID-19 diagnostic test at a large safety net hospital serving an at-risk population, providing a regulatory and logistical roadmap to broaden testing capacity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this issue of Med , Vanuytsel and colleagues 1 demonstrate how academic institutions are stepping up to the forefront of SARS-CoV-2 testing by rapidly implementing a COVID-19 diagnostic test at a large safety net hospital serving an at-risk population, providing a regulatory and logistical roadmap to broaden testing capacity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From March 23 to May 31, 2020, Addgene received about 5,300 COVID-19 plasmid requests (Fig. 1A) from ∼50 countries (Fig. 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of these, 94 plasmid requests (from 27 countries) are for CRISPR plasmids that are part of the COVID-19 collection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As with the widespread sharing of CRISPR tools in previous years, it's likely that as labs reopen, many will adopt these tools to study coronaviruses and build new diagnostic tools using the reagents from Addgene's COVID-19 collection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its emergence in on December 2019, the COVID-19 pandemic has evolved as a global health emergency [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by the novel SARS-CoV-2, a betacoronavirus structurally similar (approximately 79%) to SARS-CoV [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the first studies to report clinical data on COVID19 was a recent publication by Yang and colleagues [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Their study provided the foundation for a hypothesis put forth by Fang and colleagues indicating that diabetic and hypertensive patients exposed to ACE2 inhibitors may be at an increased risk of more severe COVID-19 [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Evidence on COVID-19’s interplay with diabetes is only recently emerging, and can currently only be considered within the context of epidemiological studies, determining diabetes mellitus (DM) as frequent comorbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aside from DM, novel hyperglycemia was recently associated with an increased with worse outcomes in COVID-19 patients, however this association was not independent of other predictors in the multivariate model [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiological associations between COVID-19 and lipid metabolism are currently not possible, since even large scale cohorts do not report on relevant measurements [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the experimental level, lipid metabolism on the cellular level has been proposed as a treatment target for COVID-19; specifically, both interactions between SARS-CoV’s spike protein with lipid rich membrane compartments, as well as the epigenetic modulations in lipid metabolism were considered as the end-point targets for the development of small molecules, aiming to prevent SARS-CoV-2 infection [19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19, the disease caused by the novel SARS-CoV-2, a betacoronavirus structurally similar to SARS-CoV."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conversely, currently there are only non-causative, observational evidence of worse outcomes for COVID-19 patients with comorbid diabetes or hyperglycemia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No study has reported on the lipid profiles of COVID-19 patients; however, lipid-targeting molecules have been proposed as agents against SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Future studies, reporting on lipid and glucose metabolism of COVID-19 patients could help elucidate the disease’s seculae and aid drug design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus was tentatively named 2019‐nCoV but officially named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) later by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses, and the disease caused by this virus was name COVID‐19 by the World Health Organization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Up to March 8 (24:00 GMT), 80 735 confirmed cases, have been diagnosed in Mainland China, causing 3119 deaths."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Missed diagnosis and misdiagnosis are currently not uncommon due to these reasons."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "The ",
            "NCBI",
            " (",
            "http://www.ncbi.nlm.nih.gov/genbank/",
            ") and ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") databases up to 14 Feb, 2020 were searched by using keywords “novel, coronavirus, complete, Wuhan” or “2019‐nCoV.”",
            "A total of 145 sequences were obtained from databases."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 512,
                "end": 516,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 518,
                "end": 554,
                "name": "http://www.ncbi.nlm.nih.gov/genbank/"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 560,
                "end": 566,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 568,
                "end": 591,
                "name": "https://www.gisaid.org/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The reference sequence was constructed by nucleotide sequence alignment (accession number: ",
            "EPI_ISL_412026",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 854,
                "end": 868,
                "name": "EPI_ISL_412026"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleic acid detection is currently the gold standard method for diagnosis of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This might partially explain why false negative results in nucleic acid detection of SARS‐CoV‐2 for diagnosis of COVID‐19 is currently not uncommon."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Starting around December 2019, an epidemic of pneumonia, which was named COVID‐19 by the World Health Organization, broke out in Wuhan, China, and is spreading throughout the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we retrieved 95 full‐length genomic sequences of SARAS‐CoV‐2 strains from the ",
            "National Center for Biotechnology Information",
            " and ",
            "GISAID",
            " databases, established the reference sequence by conducting multiple sequence alignment and phylogenetic analyses, and analyzed sequence variations along the SARS‐CoV‐2 genome."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1393,
                "end": 1438,
                "name": "National Center for Biotechnology Information"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1443,
                "end": 1449,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A relevant debate was ongoing concerning the use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat patients with Covid-19 [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following a survey by the French National Agency for Medicines and Health Products Safety (ANSM), US Food and Drug Administration (FDA) and European Medicines Agency (EMA) are investigating a potential correlation between NSAIDs and increased severity of Covid-19 symptomatology, supporting possible negative effects of these drugs to exacerbate Covid-19-related viral and bacterial pulmonary infections, leading to increased hospitalization rates and poor health outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ARBs block the effects of excessive activation of Angiotensin II AT1 receptors (AT1R), a major injury factor participating in the development of disorders of the brain, the cardiovascular system, the kidney, lipid and glucose metabolism and the immune system, enhancing inflammation and viral injury in the lung and linearly associated with viral load and lung injury in COVID-19 patients [[1], [2], [3], [4], [5]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These compounds are well-tolerated in the elderly and successfully used not only as first-line antihypertensives but also in the treatment of diabetes, kidney disease, congestive heart failure and cerebrovascular disorders, which are frequent COVID-19 comorbidities [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings are of interest because cerebrovascular complications are frequent in patients affected by COVID-19 and their prevalence increases in severe cases and in the elderly [[18], [19], [20], [21], [22], [23]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For these reasons it was reasonable to suggest that ARBs could be beneficial for the treatment of COVID-19 patients, by ameliorating inflammation, hypertension and other comorbidities and directly protecting the lung and other organs from the SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple clinical studies are in progress to determine the effect of ARB therapy in COVID-19 patients https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=angiotensin+receptor+blockers&cntry=&state=&city=&dist= and preliminary evidence indicates a reduction of critical prognosis and a lower death rate in ARB-treated COVID-19 patients [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent transcriptomic analysis of samples from COVID-19 patients and SARS-CoV-2-infected primary human alveolar cells revealed unique inflammatory profiles with excessive inflammatory cytokine release, alterations in interferon responses, macrophage and neutrophil infiltration, increased apoptosis and p53 signaling associated with lymphopenia [25,26]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We had previously reported that these changes in cultured neurons were strikingly correlated with those observed in aging, one of the most important risk factors for COVID-19, not only in the brain but also in peripheral tissues [16,17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent transcriptome analyses of samples from COVID-19 patients [25,26] provided an opportunity to correlate their findings with those obtained earlier reporting ARBs anti-inflammatory and anti-aging protective effects [16,17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed our own raw data from a previous experiment (",
            "Elkahloun et al., 2016",
            ") submitted to ",
            "Gene Expression Omnibus (GEO)",
            " under accession number ",
            "GSE67036",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 2399,
                "end": 2421,
                "name": "Elkahloun et al., 2016"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 2436,
                "end": 2465,
                "name": "Gene Expression Omnibus (GEO)"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2489,
                "end": 2497,
                "name": "GSE67036"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The raw data was submitted to ",
            "GEO",
            " under accession ",
            "GSE67036",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2529,
                "end": 2532,
                "name": "GEO"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2549,
                "end": 2557,
                "name": "GSE67036"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "We used Gene Set Enrichment Analysis (GSEA) [27] (http://www.broadinstitute.org/gsea/) to compare our data to published datasets [26] (",
            "GSE147507",
            ") downloaded from the ",
            "National Center for Biotechnology Information (NCBI)",
            " ",
            "GEO",
            " database, and [25], ",
            "CRA002390",
            " downloaded from their supplemental data and the ",
            "Genome Sequence Archive in BIG (Beijing Institute of Genomics) Data Center",
            " (",
            "https://bigd.big.ac.cn/",
            "",
            "), Chinese Academy of Sciences [28]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 2694,
                "end": 2703,
                "name": "GSE147507"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2725,
                "end": 2777,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2778,
                "end": 2781,
                "name": "GEO"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 2802,
                "end": 2811,
                "name": "CRA002390"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2860,
                "end": 2934,
                "name": "Genome Sequence Archive in BIG (Beijing Institute of Genomics) Data Center"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 2936,
                "end": 2959,
                "name": "https://bigd.big.ac.cn/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T10",
                "end": "T9"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "A complete description of these data sets is summarized in Table 1",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com) [33], Gene Ontology (http://geneontology.org/) [34], Metascape (https://metascape.org/gp/index.html#/main/step1) [35] and Jensen Compartments database (https://compartments.jensenlab.org/) [36] were used to identify gene expression profiles and canonical pathways associated with the differentially expressed genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using GSEA, we now asked the question whether this comparison would reveal normalization by Candesartan of gene signatures characteristic of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found a highly statistical positive correlation between the expression of a large number of genes upregulated by glutamate and those genes upregulated in four different SARS-CoV-2/COVID-19 human transcriptomes: a normal primary human bronchial epithelial (NHBE) cell culture infected with SARS-CoV-2 (Table 1, Fig. 1",
            "A), lung tissue post mortem samples from 2 COVID-19 patients and 2 lung biopsies from healthy controls (Table 1, Fig. 1B), peripheral blood mononuclear cells (PBMC) from 3 COVID-19 patients and 3 healthy controls (Table 1, Fig. 1C) and bronchoalveolar lavage fluid (BALF) from 2 COVID-19 patients and 3 healthy controls (Table 1, Fig. 1D)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene set enrichment plots from representative COVID-19 gene sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The figure represents gene set enrichment analysis plots showing the positive correlations of genes upregulated by glutamate (in red) and normalized by Candesartan (in blue) in our neuronal cell culture with genes upregulated in primary human bronchial epithelial cells (NHBE) infected with SARS-CoV-2 (A), lung tissue post mortem samples from COVID-19 patients (B), peripheral blood mononuclear cells from COVID-19 patients (C) and bronchoalveolar lavage fluid (BALF) from COVID-19 patients (D) (see Supplemental Table 1 for complete GSEA output)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conversely, we found a striking negative correlation between expression of these genes after Candesartan treatment and those genes upregulated in the SARS-CoV-2/COVID-19 human transcriptomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The top 20 genes with the highest rank metric scores in each enrichment dataset are listed in Table 2",
            ", that includes many genes related to cytokine and chemokine activity, chemokine receptor binding, cytokine-mediated signaling pathways, NF-κB complex, cellular response to type I interferon, type I interferon signaling pathway, response to interferon γ and response to virus, such as CXCL1, CXCL6, CXCL10, CXCL11, CXCL16, CCL4, IL1RN, IFITM1, RSAD2, PTGS2, BIRC3, AIF1 and ASS1."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When the top 20 genes with the highest rank metric scores in each enrichment dataset were compared, each dataset revealed an apparent unique transcriptome signature, the result of different types of cells included in each transcriptome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To reveal the genes most commonly associated with SARS-CoV-2 infection, we generated a list of 210 genes consistently upregulated and GSEA enriched in at least 2 out of the 4 SARS-CoV-2/COVID-19 human transcriptomes, that were also upregulated by glutamate and normalized by Candesartan in our neuronal culture."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, Supplemental Table 2 lists the individual gene associations with their dataset origin, the genes commonly upregulated in NHBE cells and PBMC, BALF and PBMC, and lung autopsies and PBMC databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From the Jensen Compartments database, we identified 50 highly significant gene expression profiles, and some of the most significant with highest numbers of genes were the NF-kappa B complex, interferon regulatory factor 7, interferon regulatory factor complex, interleukin-12 complex, interleukin-23 complex, S100A9 complex, extracellular space and Bcl-2 family protein complex (Table 3, Supplemental Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individual analysis of the list of 210 genes upregulated in at least 2 out of 4 SARS-CoV-2/COVID-19 human transcriptomes, that were also upregulated by glutamate and normalized by Candesartan in our neuronal culture (Fig. 2 and Supplemental Tables 1 and 2) revealed some genes encoding for pattern recognition receptors (PRRs) for viral entry or regulating their function (RIG-1 (DDX58), TLR4, MYD88, HERC6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Excessive inflammation with a cytokine storm and innate and adaptive immune alterations are hallmarks of COVID-19 [25,26], a disorder more severely affecting the elderly and involving not only the lung but many other organs, including the brain [37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because of the above, we asked the question whether the strong anti-inflammatory effects and normalization of the immune response by Candesartan could be in any way related to a relief of the cytokine storm and immune alterations associated with SARS-CoV-2 infection, and we compared, using GSEA, our results with the recently reported gene signature samples obtained from SARS-CoV-2 infected human cells and COVID-19 patients [25,26]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As expected, because of the different source of the materials examined, each of the datasets studied revealed unique transcriptome signatures when only the top 20 genes with highest rank metric scores in each enrichment dataset were reported (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The NHBE transcriptome included ICAM1, important for recruitment of inflammatory immune cells and participating in the COVID-19 response [38], and IL-6, a pro-inflammatory cytokine associated to poor COVID-19 response [39,40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The transcriptome from COVID-19 post mortem samples contained CYBB (NOX2) [41] a super-oxide generating enzyme forming excessive reactive oxygen species (ROS) and involved in SARS-CoV-2 infection [42] and TLR7, a Toll-like receptor essential for antiviral immunity, including the response to SARS-CoV-2 [[43], [44], [45]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PBMC transcriptome revealed HMOX1, with anti-inflammatory properties [46,47], and IL18, a proinflammatory cytokine reported to play an important role in COVID-19 [[48], [49], [50]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, when the entire lists of enriched genes were compared (Table 1 and Supplemental Table 2) we found hundreds of enriched genes in each of the datasets studied."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individual analysis of the 210-gene list revealed many genes playing major roles in COVID-19 pathology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MyD88 plays an important role in IL-6 induction during COVID-19 [57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RIG‐I is a PRR sensing RNA virus, upregulated by viral infection [58] and has been implicated in the induction of early antiviral immune responses in COVID-19 [59]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many genes are associated to the COVID-19 cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CXCL10 is a chemokine attracting macrophages and promoting T cell adhesion in response to interferon [69] and is part of the COVID-19 cytokine storm [70]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "STAT1 is activated by interferon and IL-6, polarizing the immune response specifically in macrophages, resulting in a worsened COVID-19 outcome [[75], [76], [77], [78]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increased TNFα production and release, associated with IL-1α and IL-β and inversely correlated with lymphopenia and decreased IFN-γ expression, is characteristic of severe COVID-19 [[79], [80], [81], [82]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Their upregulation may play a role in the high risk of thrombosis of COVID-19 patients [103,104]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The beneficial effect of ARB treatment may not be limited to acute SARS-CoV-2 infection and COVID-19 severity but may extend to ameliorate long-term consequences of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pulmonary fibrosis leading to pulmonary arterial hypertension and irreversible respiratory failure is likely to occur in patients recovered from acute respiratory distress syndrome (ARDS) associated with critically severe COVID-19 [57,129,130]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Old age is a major risk factor for COVID-19 progression and death [5,18,138]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been recently shown that one Alzheimer’s risk gene correlates with risk for severe COVID-19 [141]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within our 210-gene list, a genetic variant of IFITM3 has been recently associated with age-dependent COVID-19 severity [142], and ADAP2 has been proposed to participate in Alzheimer’s disease progression [143]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection not only affects the lung but extends to many other organs, including the brain, and age-related cerebrovascular disorders such as cerebral hemorrhage and stroke are not only frequent comorbidities but also novel and critical events in the presentation, progress and prognosis of COVID-19 [18,19,[21], [22], [23],146,147]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our IPA upstream regulator analysis identified many factors that may downregulate COVID-19 upregulated genes in our study, including dexamethasone, immunoglobulin, beta-estradiol, and simvastatin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dexamethasone has been proposed for acutely ill COVID-19 patients, but its use carries severe risks and needs to be carefully evaluated [152]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immunoglobulin was reported to be effective in severely ill COVID-19 patients [153]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not surprisingly, many proinflammatory cytokines (TNF, IL1B, IL6, IL13), PRRs such as TLR4 and TLR7, and inflammation-inducing drugs such as lipopolysaccharide were found to positively correlate with COVID-19 upregulated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has also been reported that ARBs ameliorate pneumonia in COVID-19 patients [[176], [177], [178], [179]], after viral infections [6,[180], [181], [182], [183], [184], [185], [186]], in diabetic patients [187] and in chronic obstructive pulmonary disease [[188], [189], [190]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Improved clinical outcome after ARB treatment of COVID-19 patients is associated with reduced IL-6 in peripheral blood, increased CD3 and CD8 T cell counts and reduced peak viral load [178] and lower concentrations of high-sensitivity C-reactive protein (hs-CRP) and procalcitonin (PCT) [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings support the present correlation of our neuronal transcriptome with that of PBMC in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the role of AT2 receptor activation in COVID-19 patients has not been studied."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Glutamate upregulated genes in neurons positively correlate with COVID-19 upregulated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Candesartan gene downregulation negatively correlates with COVID-19 upregulated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Candesartan downregulates genes involved in the COVID-19 cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Angiotensin receptor blockers (ARBs) reducing inflammation and protecting lung and brain function, could be of therapeutic efficacy in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Using GSEA, we compared our previous transcriptome analysis of neurons injured by glutamate and treated with the ARB Candesartan (",
            "GSE67036",
            ") with transcriptional signatures from SARS-CoV-2 infected primary human bronchial epithelial cells (NHBE) and lung postmortem (",
            "GSE147507",
            "), PBMC and BALF samples (",
            "CRA002390",
            ") from COVID-19 patients."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 13152,
                "end": 13160,
                "name": "GSE67036"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 13288,
                "end": 13297,
                "name": "GSE147507"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 13323,
                "end": 13332,
                "name": "CRA002390"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Hundreds of genes upregulated in SARS-CoV-2/COVID-19 transcriptomes were similarly upregulated by glutamate and normalized by Candesartan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene Ontology analysis revealed expression profiles with greatest significance and enrichment, including proinflammatory cytokine and chemokine activity, the NF-kappa B complex, alterations in innate and adaptive immunity, with many genes participating in the COVID-19 cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This supports the hypothesis of a therapeutic role for ARBs, ameliorating the COVID-19 cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, World Health Organization (WHO) declared it as Corona Viruses Disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Third, this number of peak list associated with the abstract number of peaks obtained by in-silico digestion using various databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So, we selected a medicinal plant and a drug to check its activity against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HCQ is also included in the triallist to treat COVID-19 (Liu et al., 2020; Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is theoretical, experimental, preclinical, and clinical evidence of the effectiveness of hydroxychloroquine in patients affected with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The whole genome sequence of novel coronavirus was obtained through ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov/",
            ") with accession no: ",
            "MN908947.3",
            ", 29,903bp in length and described as severe acute respiratory syndrome coronavirus 2 originated from Wuhan-Hu-1 on 18 March 2020 (Kruse, 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 628,
                "end": 632,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 634,
                "end": 663,
                "name": "https://www.ncbi.nlm.nih.gov/"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 684,
                "end": 694,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "This server determines the active peptides by comparing the calculated peak lists with already existing masses of peptides in the database, resulting in the active peptides with additional information."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We picked ",
            "Swissprot",
            " for the search database because it is nonredundant and fairly small, helpful for statistically meaningful matches (Bairoch and Apweiler, 2000)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1051,
                "end": 1060,
                "name": "Swissprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MASCOT database identifies the viruses and proteins which contain the matched peptides sequences along with complete annotation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So, from the aforementioned findings, it is confirmed that the chosen antiviral compounds are effective inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can help the immune system to fight against COVID-19 (Figures 5 and 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An rare pandemic of viral pneumonia occurs in December 2019 in Wuhan, China, which is now recognized internationally as Corona Virus Disease 2019 (COVID-19), the etiological agent classified as Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Molecular peptide docking with Moringa oleifera, phytochemicals (aqueous and ethanolic) leaf extracts of flavonoids (3.56 ± 0.03), (3.83 ± 0.02), anthraquinone (11.68 ± 0.04), (10.86 ± 0.06) and hydroxychloroquine present therapy of COVID-19 in Pakistan for comparative study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, it is proposed that these compounds are effective antiviral agents against COVID-19 and can be used in clinical trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 24 proteins of SARS-CoV-2 (Table 1) were run through our standardized workflow (Fig. 1), consisting of protein structure assessment, setting of protein protonation at pH 7.4, energy minimization in water with NaCl, 20 ns of molecular dynamics simulations, analysis of the movement trajectories, sequence identification from the nonredundant (nr) database, mapping of conservation onto structure/dynamics, and assessment of interactions with known binding partners."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dynamics and evolution for each protein were integrated together into ",
            "VIStEDD",
            ", available at RRID:",
            "SCR_018793",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 550,
                "end": 557,
                "name": "VIStEDD"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 577,
                "end": 587,
                "name": "SCR_018793"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, within the nsp10 data (RRID:",
            "SCR_018793",
            ", SARS-CoV-2, nsp10), structures of nsp10 interacting with either nsp14 or nsp16 are available, both of which show highly conserved contact sites of interaction."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 630,
                "end": 640,
                "name": "SCR_018793"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Structural mapping of human variants from 141,456 people of the ",
            "gnomADv2",
            " database for ACE2 suggests a few possible variants at the interface of S-ACE2 interaction (Fig. 6C)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 866,
                "end": 874,
                "name": "gnomADv2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "That database can be used by groups to investigate species where SARS-CoV-2 may be able to enter cells, with variants that enhance or inhibit binding."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For those proteins without structural homologs, we utilized models that are part of the I-TASSER SARS-CoV-2 database (39)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We established the ",
            "Viral Integrated Structural Evolution Dynamic Database (VIStEDD",
            " at RRID:",
            "SCR_018793",
            " ) to facilitate future discoveries and educational use."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1269,
                "end": 1332,
                "name": "Viral Integrated Structural Evolution Dynamic Database (VIStEDD"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1341,
                "end": 1351,
                "name": "SCR_018793"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using this quantitative matrix, we elucidated 47 potential functional missense variants from genomic databases within ACE2/SLC6A19/transmembrane serine protease 2 (TMPRSS2), warranting genomic enrichment analyses in SARS-CoV-2 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose that this SARS-CoV-2 database may aid research into the ongoing pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous reports indicated that the emergence of the novel coronavirus (SARS-CoV-2) infection (COVID-19) had raised global concern and was characterized as a pandemic event by the World Health Organization on March 11, 2020.1, 2, 3 Till March 18, 2020, it has spread to 146 countries, including Taiwan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "People in Taiwan and mainland China travel frequently, which put Taiwan at a great risk of acquiring an epidemic of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taiwan has been on constant alert and react rapidly to epidemics change from China ever since the severe acute respiratory syndrome (SARS) epidemic in 2003 and has done much effort on the containment of COVID-19 with success."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Till March 18, 2020, there are only 100 cases of COVID-19 noted in Taiwan, including 79 imported cases and 21 cases belonging to seven occasions of limited local transmission (six family clusters and two transmissions in social societies)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The most interesting point of this patient is where she contracted her COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, despite that the median incubation period of COVID-19 was 5.1 days, it might be as long as more than three weeks in some extreme cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The phylogenetic tree was generated and modified for display purposes from ",
            "Nextstrain",
            " (",
            "https://nextstrain.org/ncov",
            "), which uses genetic sequences and metadata from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/CoV2020/",
            ") and sequence submission date for the horizontal axis."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1198,
                "end": 1208,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1210,
                "end": 1237,
                "name": "https://nextstrain.org/ncov"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1287,
                "end": 1293,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 1295,
                "end": 1326,
                "name": "https://www.gisaid.org/CoV2020/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To our best knowledge, in late February and early March, several foreign COVID-19 patients who had travel histories to Egypt were reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further phylogenetic analysis including viral sequences derived from the 45 confirmed SARS-CoV-2 infections on the quarantined Nile cruise boat will help to delineate the outbreak on Nile tourism boat and its impact on the COVID-19 epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In planning for our health system’s anticipated COVID-19 pandemic response scenario, our workgroup planned initially to support only low-acuity, non–COVID-19 populations requiring oral and/or intramuscular injections; in a stepwise approach to increasing acuity, limited gravity-flow infusions would be supported by the closest hospital pharmacy with sterile compounding capabilities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our workgroup anticipated that the alternate care site would have limited nurse staffing due to mass deployment for high-acuity, COVID-19–related patient care needs in existing hospitals throughout the health system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Purpose  Guidance on alternate care site planning based on the experience of a health-system pharmacy department in preparing for an expected surge in coronavirus disease 2019 (COVID-19) cases is provided."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In disaster response situations such as the COVID-19 pandemic, healthcare institutions may be compelled to transition to a contingency care model in which staffing and supply levels are no longer consistent with daily practice norms and, while usual patient care practices are maintained, establishment of alternate care sites (eg, a convention center) may be necessitated by high patient volumes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Available resources to assist hospitals and health systems in alternate care site planning include online guidance posted within the COVID-19 resources section of the US Army Corps of Engineers website, which provides recommended medication and supply lists; and the Federal Healthcare Resilience Task Force’s alternate care site toolkit, a comprehensive resource for all aspects of alternate care site planning, including pharmacy services."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, these data show the utility of genomics to complement other tools in the response to, and containment of, the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 cases are slowly increasing in number in Africa and genetic mutations are expected to accumulate as the virus spreads."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As well as ongoing mobilisation of resources to support the COVID-19 outbreak response, it is crucial for Africa to develop sustainable approaches, with a vision to change the siloed pathogen-specific diagnostics methods and implement digital and genomic transformation in the public health system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SENTINEL, a new international initiative led by the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) in Nigeria and the Broad Institute, is utilising ultra-sensitive genomic technologies to develop a pandemic pre-emption system that detects viral threats in real time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) termed the disease as coronavirus disease-2019 (COVID-19) on February 11, 2020 [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With transmission of the virus possible before the onset of clinical signs, the COVID-19 outbreak has quickly expanded to worldwide [18–20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of August 18, 2020, a total of 21,756,357 confirmed cases of COVID-19 and 771,635 deaths have been reported in more than 200 countries and territories."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first case of COVID-19 in Turkey was confirmed on March 112020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reads were aligned to the previously assembled sequence of the SARS-CoV-2 genome (",
            "GenBank",
            " Accession: ",
            "MN908947.3",
            ") using the Burrows-Wheeler aligner v.0.7.1 with the MEM algorithm [25]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 571,
                "end": 578,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 590,
                "end": 600,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For multiple sequence alignment, complete (>29,000bp) and high-coverage genomes (n = 3970) were used from the ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 783,
                "end": 789,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GISAID",
            " strain genomes including the genome of our strain were aligned using the MAFFT v7.450 tool [28]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 804,
                "end": 810,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The whole genome sequence was submitted to ",
            "GenBank",
            " (ID:",
            "MT327745.1",
            ") and ",
            "GISAID",
            " (ID: ",
            "EPI_ISL_424366",
            ") and the raw data deposited on ",
            "SRA",
            " (",
            "SAMN15062833",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 951,
                "end": 958,
                "name": "GenBank"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 963,
                "end": 973,
                "name": "MT327745.1"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 979,
                "end": 985,
                "name": "GISAID"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 991,
                "end": 1005,
                "name": "EPI_ISL_424366"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1037,
                "end": 1040,
                "name": "SRA"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1042,
                "end": 1054,
                "name": "SAMN15062833"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "Taken together, these results suggest that a SARS-CoV-2 strain named hCoV-19/Turkey/ERAGEM-001/2020 was successfully isolated from the nasopharyngeal sample of a patient in Turkey with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to published case reports and ",
            "GISAID",
            " metadata entries, at least 9 SARS-CoV-2 samples in the nearby clusters had a recent travel history to Iran [30]."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1302,
                "end": 1308,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GISAID",
            " had only one full genome sequence of SARS-CoV-2 from Iran, which also included the two key mutations (G1397A and G29742T)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 1426,
                "end": 1432,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, analysis of the NP partial gene sequences of the Iranian samples in ",
            "GISAID",
            " showed that all of the Iranian partial sequences (n = 15) also contain the T28688C, which is another key single nucleotide polymorphism (SNP) of this clade."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1637,
                "end": 1643,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our strain also contained G23876A, a non-synonymous mutation in the S gene, which was not observed in any other full genome sequences in ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 1938,
                "end": 1944,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we isolated the SARS-CoV-2 from the nasopharyngeal sample of a patient in Turkey with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lastly, we have compared the whole genome of hCoV-19/Turkey/ERAGEM-001/2020 with a dataset of 3970 available SARS-CoV-2 complete genomes from different countries retrieved from ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 2244,
                "end": 2250,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reason for the high fraction of Australian cases in this cluster was possibly due to the high number of submitted sequences, as Australia was the third country that had the most sequences submitted to ",
            "GISAID",
            " by April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Dataset",
                "start": 2457,
                "end": 2463,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, hCoV-19/Turkey/ERAGEM-001/2020 has the G23876A mutation on the S gene, which is not found in any other full genome sequences in ",
            "GISAID",
            ", including the Australian cluster."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Dataset",
                "start": 2622,
                "end": 2628,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and associated with severe respiratory illness emerged in Wuhan, China, in late 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no specific treatments or licensed vaccines available for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We isolated SARS-CoV-2 from the nasopharyngeal sample of a patient in Turkey with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 infects mainly elderly and people with cardiovascular risk, such as hypertension (Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Every clinician recognizes that the virus does not cause disease similar to influenza, which carries the risk that designing targeted therapies based on the pathogenesis of influenza might fail in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Research on Sars-CoV pathogenesis which might be very similar to Sars-CoV-2 pathogenesis has focused the discussion on ACE inhibitors, recombinant ACE2, and ARBs and how they could fit in the pathogenesis of COVID-19, since these pathways were extensively studied in SARS (Fang et al., 2020; Batlle et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we describe the clinical observations that brought the clues for explaining the potential pathophysiological mechanisms, and offer a rationale for targeted treatment at different stages of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast to patients with common forms of ARDS, approximately 70% of patients with severe COVID-19 show an only slightly decreased pulmonary compliance (L-type) (Gattinoni et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose it all starts with ACE2 and its role in the kallikrein-kinin system, which to date has not been investigated in the pathogenesis of SARS or COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical picture of COVID-19 is in line with a single-organ failure of the lung that is due to edema at the site of inflammation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, complement activation has been described and could play a role in this stage of disease, and this might be amendable to C5 blockade with eculizimab with which a randomized trial in COVID-19 is being performed (",
            "NCT04288713",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1546,
                "end": 1557,
                "name": "NCT04288713"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients can present with pulmonary edema early in disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we hypothesize that a kinin-dependent local lung angioedema via B1R and eventually B2R is an important feature of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose that blocking the B2R and inhibiting plasma kallikrein activity might have an ameliorating effect on early disease caused by COVID-19 and might prevent acute respiratory distress syndrome (ARDS)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic represents an unprecedented threat to global health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Common symptoms include a fever and persistent cough and COVID-19 patients also often experience an excess of fluid in the lungs, which makes it difficult to breathe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 virus, which causes COVID-19, enters the lining of the lungs via an enzyme called the ACE2 receptor, which is present on the outer surface of the lungs’ cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a result, much attention has turned to the potential link between this hormone system in relation to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This led van de Veerdonk et al. to propose that the excess of fluid in the lungs seen in COVID-19 patients may be because kinins are not being neutralized due to the shortage of the ACE2 receptor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "If this hypothesis is correct, it would mean that directly inhibiting the receptor for the kinins (or the proteins that they come from) may be the only way to stop fluid leaking into the lungs of COVID-19 patients in the early stage of disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "If that work provides a proof of concept, it means that existing treatments and registered drugs could potentially help patients with COVID-19, by preventing the need for mechanical ventilation and saving many lives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease-19 (COVID-19), has infected millions of people worldwide since its identification in December 2019, resulting in more than 400 000 deaths to date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the substantial reach of the COVID-19 pandemic in areas with high HIV prevalence, there are very limited data regarding the clinical impact of SARS-CoV-2 infection on PLWH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 also leads to marked immune dysregulation, with severe cases manifesting a dramatic hyperinflammatory syndrome that causes respiratory failure and multiorgan dysfunction [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lack of knowledge regarding the interaction of HIV- and COVID-19–related immune dysfunction have led to uncertainty regarding appropriate clinical and policy guidance for the management and counseling of PLWH during the SARS-CoV-2 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified 405 patients not living with HIV, matching 1 PLWH to up to 5 patients by age (±2.5 years), sex, race/ethnicity, and calendar week of infection (to account for temporally associated changes in COVID-19 management and differences in follow-up time)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Oxygen supplementation requirements on admission were collected, verified via chart review, and used to categorize COVID-19 severity using published criteria [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each of these biomarkers was also ascertained, when available, after the diagnosis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also stratified baseline laboratory measures by COVID-19 severity for PLWH, testing for differences in measures by severity category using ordinal logistic regression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To compare cumulative incidence of death by HIV status accounting for potential confounding factors, we fit a multivariable survival model using Fine-Grey competing risk methods, including demographics, COVID-19 severity, comorbid conditions, and laboratory values that differed by HIV status [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 4402 patients hospitalized for COVID-19 during the study period, 88 (2%) were PLWH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median age of PLWH hospitalized with COVID-19 was 61 years (Table 1; interquartile range [IQR], 54–67), and most PLWH were black (40%) or Hispanic/Latino (30%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PLWH and uninfected persons had similar COVID-19 severity on admission as measured by oxygen supplementation requirements (P = .15)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Higher CRP values were present in PLWH with more severe COVID-19 on admission (Supplementary Table 2; P = .005)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Concern that COVID-19 might be more severe in persons with immunodeficiency or immune dysregulation has been raised since the emergence of the earliest cases [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, outcomes analyses for PLWH during the COVID-19 pandemic have been limited, consisting of small case reports or series [12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A single center in Spain reported outcomes for 5 males living with HIV hospitalized with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Larger uncontrolled series from New Jersey (13 hospitalized patients), New York City (31 hospitalized patients), and Madrid, Spain (28 hospitalized patients) also subsequently demonstrated COVID-19 outcomes for PLWH similar to those described for the general population [14–16]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is broadly consistent with our finding that respiratory failure that requires mechanical ventilation and death were not more frequent in PLWH when compared with demographically similar persons with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lack of outcome differences is even more striking when it is noted that COPD, cancer, and smoking, which were identified as risk factors linked to worse COVID-19 outcomes in several previous studies, were far more prevalent in PLWH in our cohort than in comparator patients [17, 18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several factors have supported theoretical risks of worse COVID-19 in PLWH, including incomplete immune reconstitution and evidence of persistent immune activation in many patients prior to the pandemic [19, 20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, increased IL-6 and D-dimer measures have been independently associated with chronic HIV infection [21, 22] and have also been closely linked with COVID-19 severity in data mostly from persons not living with HIV [23, 24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neither biomarker differed on presentation for patients by HIV status nor was either associated with COVID-19 severity at presentation for PLWH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among PLWH, CD4 decline was noted in the majority of patients with available data, consistent with existing immunologic data on COVID-19 natural history, but the decrease in CD4 percentage was not large [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We did not find evidence of associations between immunologic measures (either decreases from pre–COVID-19 values or low values at the time of presentation) and adverse COVID-19 outcomes for PLWH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Antiretroviral medications have been evaluated for treatment of COVID-19 [26]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was no difference in COVID-19 severity on admission by HIV status ( P = .15)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are limited data on coronavirus disease 2019 (COVID-19) clinical outcomes for people living with human immunodeficiency virus (PLWH)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We report outcomes for a cohort of hospitalized PLWH with COVID-19 compared with demographically matched comparators."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fifty-five sera from convalescent COVID-19 patients and 18 control sera (Supplementary Table 2) were screened on the peptide microarray for both IgG and IgM responses (Fig. 1a and Supplementary Fig."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For IgG, COVID-19 patients were completely separated from controls, and distinct and specific signals were shown for some peptides."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IgG antibodies against this epitope can be detected in ~90% of COVID-19 patients, indicating that it is an extremely dominant epitope."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The peptide microarray data are deposited in the ",
            "Protein Microarray Database",
            " (",
            "http://www.proteinmicroarray.cn",
            ") under the accession number ",
            "PMDE242",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 515,
                "end": 542,
                "name": "Protein Microarray Database"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 544,
                "end": 575,
                "name": "http://www.proteinmicroarray.cn"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 604,
                "end": 611,
                "name": "PMDE242"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Analysis of binding to dimeric human ACE2, incorporating avidity effects, was also analyzed for the RBDs that did not bind monomeric ACE2 (D-F, right)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the phenotypic impacts of mutations that have appeared in the SARS-CoV-2 RBD to date, we downloaded all 31,570 spike sequences available from ",
            "GISAID",
            " (",
            "Elbe and Buckland-Merrett, 2017",
            ") on May 27, 2020 and identified RBD amino acid mutations present in high-quality clinical isolates."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 304,
                "end": 310,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 312,
                "end": 343,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For each threshold of ",
            "GISAID",
            " observation counts, 1 million random sub-samples of single-nucleotide-accessible amino acid changes were generated at the same sample size as the true mutation set (n = 98, 42, and 13 for the ≥ 1, ≥ 2, and ≥ 6 thresholds)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 466,
                "end": 472,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A P-value was determined as the fraction of sub-samples with median mutational effect on binding or expression equal to or greater than that of the actual ",
            "GISAID",
            " mutation set (dashed vertical line)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 851,
                "end": 857,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The observation that the set of mutations observed in ",
            "GISAID",
            " have a more favorable median mutational effect on binding and expression than randomly sampled mutations indicates the action of purifying selection for ACE2 binding and RBD stability."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 949,
                "end": 955,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Random sub-samples were generated as in (B), and the maximum affinity-enhancing effect of mutations in each sub-sample was compared to that in the actual ",
            "GISAID",
            " mutation set."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1295,
                "end": 1301,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A P-value was determined as the fraction of sub-samples with a maximum effect on binding equal to or greater than in the actual ",
            "GISAID",
            " mutation set (vertical dashed line)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1444,
                "end": 1450,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We do not see evidence for selection for enhanced ACE2 binding, as randomly sampled mutations generally contain mutations with stronger affinity-enhancing effects than observed in the ",
            "GISAID",
            " mutation set."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1672,
                "end": 1678,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Last, we validated our deep mutational scanning for mutations that are especially prevalent among naturally occurring sequences in ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1824,
                "end": 1830,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Spike receptor binding domain (RBD) from SARS-CoV-2 (isolate Wuhan-Hu-1, ",
            "GenBank",
            " : ",
            "MN908947",
            ", residues N331-T531) and additional sarbecovirus homologs (RaTG13, ",
            "GenBank",
            ": ",
            "MN996532",
            "; GD-Pangolin consensus from Lam et al. (2020); SARS-CoV-1 Urbani, ",
            "GenBank",
            ": ",
            "AY278741",
            "; WIV1, ",
            "GenBank",
            ": ",
            "KF367457",
            " (identical RBD sequence to WIV16); LYRa11, ",
            "GenBank",
            ": ",
            "KF569996",
            "; Rp3, ",
            "GenBank",
            ": ",
            "DQ071615",
            "; HKU3-1, ",
            "GenBank",
            ": ",
            "DQ022305",
            "; Rf1, ",
            "GenBank",
            ": ",
            "DQ412042",
            "; ZXC21, ",
            "GenBank",
            ": ",
            "MG772934",
            "; ZC45, ",
            "GenBank",
            ": ",
            "MG772933",
            "; and BM48-31, ",
            "GenBank",
            ": ",
            "NC014470",
            ") were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1909,
                "end": 1916,
                "name": "GenBank"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1919,
                "end": 1927,
                "name": "MN908947"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1995,
                "end": 2002,
                "name": "GenBank"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 2004,
                "end": 2012,
                "name": "MN996532"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2079,
                "end": 2086,
                "name": "GenBank"
            },
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 2088,
                "end": 2096,
                "name": "AY278741"
            },
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 2104,
                "end": 2111,
                "name": "GenBank"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 2113,
                "end": 2121,
                "name": "KF367457"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 2165,
                "end": 2172,
                "name": "GenBank"
            },
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 2174,
                "end": 2182,
                "name": "KF569996"
            },
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 2189,
                "end": 2196,
                "name": "GenBank"
            },
            false,
            {
                "id": "T21",
                "type": "AccessionNumber",
                "start": 2198,
                "end": 2206,
                "name": "DQ071615"
            },
            false,
            {
                "id": "T22",
                "type": "Repository",
                "start": 2216,
                "end": 2223,
                "name": "GenBank"
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 2225,
                "end": 2233,
                "name": "DQ022305"
            },
            false,
            {
                "id": "T24",
                "type": "Repository",
                "start": 2240,
                "end": 2247,
                "name": "GenBank"
            },
            false,
            {
                "id": "T25",
                "type": "AccessionNumber",
                "start": 2249,
                "end": 2257,
                "name": "DQ412042"
            },
            false,
            {
                "id": "T26",
                "type": "Repository",
                "start": 2266,
                "end": 2273,
                "name": "GenBank"
            },
            false,
            {
                "id": "T27",
                "type": "AccessionNumber",
                "start": 2275,
                "end": 2283,
                "name": "MG772934"
            },
            false,
            {
                "id": "T28",
                "type": "Repository",
                "start": 2291,
                "end": 2298,
                "name": "GenBank"
            },
            false,
            {
                "id": "T29",
                "type": "AccessionNumber",
                "start": 2300,
                "end": 2308,
                "name": "MG772933"
            },
            false,
            {
                "id": "T30",
                "type": "Repository",
                "start": 2323,
                "end": 2330,
                "name": "GenBank"
            },
            false,
            {
                "id": "T31",
                "type": "AccessionNumber",
                "start": 2332,
                "end": 2340,
                "name": "NC014470"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T10",
                "end": "T11"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T12",
                "end": "T13"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T14",
                "end": "T15"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T16",
                "end": "T17"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T18",
                "end": "T19"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T20",
                "end": "T21"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T22",
                "end": "T23"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T24",
                "end": "T25"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T26",
                "end": "T27"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T28",
                "end": "T29"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T30",
                "end": "T31"
            }
        ]
    },
    {
        "sen": [
            "All 31,570 spike sequences on ",
            "GISAID",
            " as of 27 May 2020 were downloaded and aligned via mafft (Katoh and Standley, 2013)."
        ],
        "lab": [
            false,
            {
                "id": "T32",
                "type": "Dataset",
                "start": 2492,
                "end": 2498,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All amino-acid mutations among ",
            "GISAID",
            " sequences were enumerated."
        ],
        "lab": [
            false,
            {
                "id": "T33",
                "type": "Dataset",
                "start": 2614,
                "end": 2620,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We excluded any mutation from our curated set of ",
            "GISAID",
            " mutations if it was solely observed on sequence backgrounds containing at least one undetermined X character in the RBD sequence; however, sequences with X characters were allowed to contribute to observations of mutation count for mutations that were observed on at least one other high-coverage RBD sequence."
        ],
        "lab": [
            false,
            {
                "id": "T34",
                "type": "Dataset",
                "start": 2697,
                "end": 2703,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To characterize patterns of selection on amino-acid mutations observed among ",
            "GISAID",
            " sequences, we conducted permutation tests as described in the Figure S7 legend."
        ],
        "lab": [
            false,
            {
                "id": "T35",
                "type": "Dataset",
                "start": 3092,
                "end": 3098,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We acknowledge all ",
            "GISAID",
            " contributors for their sharing of sequencing data (https://github.com/jbloomlab/SARS-CoV-2-RBD_DMS/blob/master/data/alignments/Spike_GISAID/gisaid_hcov-19_acknowledgement_table.xls)."
        ],
        "lab": [
            false,
            {
                "id": "T36",
                "type": "Dataset",
                "start": 3198,
                "end": 3204,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The full sequence of this plasmid is available at ",
            "https://github.com/jbloomlab/SARS-CoV-2-RBD_DMS/blob/master/data/plasmid_maps/2736_HDM_IDTSpike_EcoKozak.gb",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T37",
                "type": "URL",
                "start": 3438,
                "end": 3545,
                "name": "https://github.com/jbloomlab/SARS-CoV-2-RBD_DMS/blob/master/data/plasmid_maps/2736_HDM_IDTSpike_EcoKozak.gb"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We present an interactive visualization and open analysis pipeline to facilitate use of our dataset for vaccine design and functional annotation of mutations observed during viral surveillance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The work identifies structurally constrained regions of the spike RBD that would be ideal targets for COVID-19 countermeasures and demonstrates that mutations in the virus that enhance ACE2 affinity can be engineered but have not, to date, been naturally selected during the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 (coronavirus disease 2019) has become a global pandemic, fueled by the rapid spread of the coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a positive-strand RNA virus (Wu et al., 2020a; Sanche et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While large-scale comparisons are not currently feasible due to lack of datasets measuring viral transcript localization, this example provides some reassurance that RNA-GPS’ predicted viral residencies are reasonable."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(B) To evaluate the effect of the potentially noisy mitochondrial examples in our APEX-seq training set on predicted SARS-CoV-2 residencies, we trained a “denoised” variant of RNA-GPS on a subsetted dataset that excludes these examples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For additional analysis of the mitochondrial dataset and predictions, see Figure S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To ensure that our results have not been driven by potentially noisy data in this regime, we excluded nuclear-encoded, “noncanonical” mitochondrial matrix transcripts with relatively low APEX-seq enrichment signal (lowest 20% of log-fold-change enrichment scores) and retrained RNA-GPS on this adjusted dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This “denoised” model recapitulates the same SARS-CoV-2 residency toward the mitochondrial matrix and nucleolus (Figure 2B), suggesting that our predictions are robust to potential noise in the training data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used “RNA subcellular residency” rather than “RNA localization” to describe RNA-GPS prediction results, as this is more reflective of the underlying APEX-seq training data and its inherent differences compared with viral transcripts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 viral genomes were programmatically queried from the ",
            "NCBI",
            " ",
            "GenBank",
            " online database using the BioPython library’s Entrez module (Cock et al., 2009)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1606,
                "end": 1610,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1611,
                "end": 1618,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The model was implemented in PyTorch and was trained to minimize a binary cross-entropy loss using the Adam optimizer (Kingma and Ba, 2014) with a batch size of 1, with early stopping based on validation set area under the receiver operating characteristic (AUROC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Localization within this dataset is expressed as an enrichment score compared to the rest of the cell."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As is conventional, the validation set was used for hyperparameter tuning and model architecture tuning."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We use a database of 102 RNA binding protein binding motifs (Ray et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genes were compared in an overrepresentation test against a reference list of all genes in the Homo sapiens database using Fisher’s Exact test, with false discovery rate correction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is worth mentioning that each Baltimore’s group is represented in the human, non-human primate, avian and fish viral sequence data sets, albeit in different proportions (Fig 3A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This depletion is shared in all viral datasets while the NTC depletion is specific to a subpopulation of human and non-human primate viral sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The APOBEC family of genes also counts the AID (or AICDA), APOBEC1, APOBEC2 and APOBEC4 genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "AID is critical for somatic hypermutation and class switch recombination by editing the immunoglobulin loci in B cells [39]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, APOBEC1 and AID appear also to participate to the restriction of viruses and retroelements [1,42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Evidence for AID and APOBEC1 evolutionary footprints were investigated by looking for the depletion of their favored motifs, respectively WRC for AID [43] and WCW for APOBEC1 [44]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The distributions of the WRC and NNGYWN ratios do not point towards viruses significantly footprinted by AID at the whole genome level (S10B Fig)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, putatively AID-footprinted genes were identified in several double strand DNA viruses, notably the B-cell-infecting virus EBV (S10C Fig)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we identified several AID-footprinted genes in the EBV genome which supports recent observations made by Martinez et al. [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Those genes are not spatially clustered and further investigation would be necessary to link the detected footprint to AID activity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We downloaded complete viral genomes from the “",
            "NCBI Virus",
            "” database (",
            "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/",
            ") as released in April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1460,
                "end": 1470,
                "name": "NCBI Virus"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1482,
                "end": 1529,
                "name": "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "We retrieved non-human primate viruses by selecting “Primate” for the criterion “Host” and by deducting the human viruses from this data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset of Human viruses was supplemented by manually curated human virus complete genome sequences from the “",
            "NCBI nucleotide",
            "” database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1814,
                "end": 1829,
                "name": "NCBI nucleotide"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GenBank",
            " accession ID’s are treated as unique and listed in the S1, S2 and S3 Tables."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1841,
                "end": 1848,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus Disease 2019 (COVID-19) was first described in 2019 in Wuhan city of Hubei state, China, as a pneumonia caused by a previously unknown pathogen."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The International Coronavirus Study Group named the responsible virus initially as 2019-nCoV and later as SARS-CoV-2. World Health Organization (WHO), named the disease caused by SARS-CoV-2 as COVID-19 [1], [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is no specific antiviral drug for treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, severe COVID-19 patients have elevated levels of pro-inflammatory cytokines IL-6, IL-1β, IL-2, IL-8, IL-17, G-CSF, GM-CSF, M-CSF, IP10, MCP1, MIP1α (CCL3) and TNF-α in their sera [19], [20], this burst of cytokines is defined as cytokine release syndrome (CRS) and is also common during CAR T cell therapies, macrophage activation syndrome (MAS) or hemophagocytic lymphohistiocytosis (HLH) [21], [22], [23], COVID-19 pathology mainly consists of pulmonary lesions, and thus, presents similar characteristics with interferonopathies which root from intrinsic hyperactive IFN response."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, neutralizing IL-6 (via tocilizumab) showed promise in severe COVID-19 patients [24], [25], IL-1β or TNF-α blockers are considered or planned for clinical trials [19], [22], [23],",
            "Herein, we discuss the potential use of TLR7 agonists in the early stages of COVID-19 treatment."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rHCoVs-OC43 50% tissue culture infectious dose (TCID50) was determined by indirect immunofluorescence assay (IFA) according to a previously described method (Reed, 1938)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, rOC43-ns2DelRluc (100 TCID50) showed pathogenicity in BALB/c mice, which exhibited neurological symptoms identical to those caused by the parental virus after intracerebral inoculation (Shen et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, these two mouse strains were infected with 104 TCID50 of rOC43-ns2DelRluc or HCoV-OC43-WT by intranasal inoculation in order to determine its infection of the respiratory tract in vivo."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in the present study, we found that both BALB/c or C57BL/6 suckling mice (<12-days old) infected with HCoV-OC43 at a dose of 104 TCID50 showed 100% mortality and similar sensitivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To confirm these observations and the dissemination of the recombinant virus, the viral load in different tissues was determined using an IFA in BHK-21 cells or real-time qRT-PCR at 6 dpi via intranasal inoculation of 104 TCID50 of rOC43-ns2DelRluc."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To perform BLI of rOC43-ns2DelRluc in vivo, BALB/c and C57BL/6 mice were intranasally inoculated with 104 TCID50 of rOC43-ns2DelRluc or HCoV-OC43-WT, monitored over time, and bioluminescence intensity was determined (Fig. 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, individual BALB/c mice were either inoculated intracerebrally with 100 TCID50 or intranasally with 104 TCID50 of rOC43-ns2DelRluc and monitored over time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mice were intracerebrally infected with 100 TCID50 of rOC43-ns2DelRluc, and bioluminescence intensity was measured daily (Fig. 5",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both the WHO and European Centre for Disease Prevention and Control (ECDC) have recommended the evaluation of convalescent plasma for the prevention and treatment of the COVID-19 disease in controlled trials (WHO/HEO/R&D Blueprint (nCoV)/2020.1) [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, several trials have shown that convalescent plasma reduced the viral load and was safe for the treatment of patients with COVID-19 [12,13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have recently reviewed and summarized the information on dozens of safe-in-man BSAAs in the freely accessible database (",
            "https://drugvirus.info/",
            ") [17,18,19]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 523,
                "end": 546,
                "name": "https://drugvirus.info/"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, clinical investigations have started recently into the effectiveness of BSAAs such as lopinavir, ritonavir, remdesivir, hydroxychloroquine and arbidol against COVID-19 (",
            "NCT04252664",
            ", ",
            "NCT0425487",
            ", ",
            "NCT04255017",
            ", ",
            "NCT04261517",
            " and ",
            "NCT04260594",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 743,
                "end": 754,
                "name": "NCT04252664"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 756,
                "end": 766,
                "name": "NCT0425487"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 768,
                "end": 779,
                "name": "NCT04255017"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 781,
                "end": 792,
                "name": "NCT04261517"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 797,
                "end": 808,
                "name": "NCT04260594"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We reviewed the current landscape of the available diagnostic tools, as well as the emerging treatment and prophylactic options for the SARS-CoV-2 pandemic and have summarized the information in a database that can be freely accessed at https://sars-coronavirus-2.info."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The information in the database was obtained from ",
            "PubMed",
            ", ",
            "clinicaltrials.gov",
            ", ",
            "DrugBank",
            ", ",
            "DrugCentral",
            ", the ",
            "Chinese Clinical Trials Register (ChiCTR)",
            " and ",
            "EU Clinical Trials Register",
            " databases [28,29,30], as well as other public sources."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1131,
                "end": 1137,
                "name": "PubMed"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1139,
                "end": 1157,
                "name": "clinicaltrials.gov"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1159,
                "end": 1167,
                "name": "DrugBank"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1169,
                "end": 1180,
                "name": "DrugCentral"
            },
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1186,
                "end": 1227,
                "name": "Chinese Clinical Trials Register (ChiCTR)"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1232,
                "end": 1259,
                "name": "EU Clinical Trials Register"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 statistics are automatically exported from the ",
            "COVID-19 Data Repository",
            " by the ",
            "Center for Systems Science and Engineering (CSSE)",
            " at Johns Hopkins University (",
            "https://github.com/CSSEGISandData/COVID-19",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1375,
                "end": 1399,
                "name": "COVID-19 Data Repository"
            },
            false,
            {
                "id": "T14",
                "type": "Creator",
                "start": 1407,
                "end": 1456,
                "name": "Center for Systems Science and Engineering (CSSE)"
            },
            false,
            {
                "id": "T15",
                "type": "URL",
                "start": 1486,
                "end": 1528,
                "name": "https://github.com/CSSEGISandData/COVID-19"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T13",
                "end": "T15"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T14",
                "end": "T15"
            }
        ]
    },
    {
        "sen": [
            "We isolated seven SARS-CoV-2 strains from 22 NPS samples of COVID-19 patients using Vero-E6 cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We evaluated the neutralization capacity of seven serum samples obtained from patients recovered from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five samples from patients recovered from COVID-19 had serum sensitivity scores (SSS) > 5 and rescued >50% cells from virus-mediated death at 1 mg/mL (Figure 2a,b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, these results suggest that patients diagnosed with COVID-19 produce different immune responses to the SARS-CoV-2 infection and that the neutralization capacity of convalescent sera declines with time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Through the literature review, we made a database to summarize safe-in-man BSAAs (",
            "https://drugvirus.info/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "URL",
                "start": 2202,
                "end": 2225,
                "name": "https://drugvirus.info/"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results suggest that COVID-19 patients respond differently to the SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, the neutralization test allowed us to identify the most potent sera from patients recovered from COVID-19 for the treatment of SARS-CoV-2-infected patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the recent safety study on 5000 hospitalized patients transfused under the U.S. Food and Drug Administration’s national Expand Access Program for COVID-19 revealed no toxicity (https://doi.org/10.1101/2020.05.12.20099879)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, drug repositioning for COVID-19 provides unique translational opportunities, including a substantially higher probability of success to the market as compared with developing new virus-specific drugs and vaccines, as well as significantly reduced costs and timelines to clinical availability [26,46,47]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we developed a website to disseminate the knowledge on available and emerging treatments of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was called SARS-CoV-2 (causing the coronavirus disease 2019, COVID-19) and rapidly spread from animals (pangolins or bats as possible sources) to humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While the diagnosis of COVID-19 is based on the amplification of the viral genome in real-time PCR with specific probes, the current treatment of affected individuals is limited to a mixture of a broad-spectrum of antiviral drugs [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The interaction between the drug and protein was obtained using the ",
            "Matador",
            " and ",
            "DGIdb",
            " database [29,30]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 460,
                "end": 467,
                "name": "Matador"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 472,
                "end": 477,
                "name": "DGIdb"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eighty-three percent of the genes (435/526) that correlated with ACE2 in ",
            "TCGA",
            " were also correlated in at least one of the other three independent datasets (",
            "GSE994",
            ", ",
            "GSE17913",
            " and ",
            "GTEx",
            ", p-value < 0.05) (Figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 569,
                "end": 573,
                "name": "TCGA"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 652,
                "end": 658,
                "name": "GSE994"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 660,
                "end": 668,
                "name": "GSE17913"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 673,
                "end": 677,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the top 10 most significant genes correlated to ACE2 in ",
            "TCGA-LUAD",
            " dataset (Table 1), two genes (CRIP2 and ACACA) were also found in ",
            "GSE994",
            ", ACSL5 was found in ",
            "GSE17913",
            " and LRRK2, HSD17B4, EPHX1, MCCC2, GSTA4, HGD, and ROS1 were found in ",
            "GTEx",
            " dataset."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 769,
                "end": 778,
                "name": "TCGA-LUAD"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 845,
                "end": 851,
                "name": "GSE994"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 872,
                "end": 880,
                "name": "GSE17913"
            },
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 950,
                "end": 954,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Starting from 7338 drugs originated by the Matador and DGIdb database, we evaluated if drug target genes were overrepresented in the network."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although several recent papers have come out on the possible drug treatment options for COVID-19 and several clinical trials are proposing different compounds for the treatment, we haven’t found any drugs among those that we’d propose, either in clinical trials or in other publications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, an in silico approach enlarged to all possible gene networks altered by COVID-19 disease found several potential therapeutic molecules [53], and although they found some compounds with anti-inflammatory properties, none of them were common with the ones that we found."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nimesulide belongs to the class of sulphonamides; it is a non-steroidal anti-inflammatory drug (NSAID), which preferentially inhibits the enzyme cyclooxygenase-2 (COX-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The induction by estrogen and androgen of ACE2, and possibly of IL2RA, established a negative correlation between ACE2 expression, age of the subjects and COVID-19 fatality at both population and molecular levels [62]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, we used the gene expression profiles from public datasets including ",
            "The Cancer Genome Atlas",
            ", ",
            "Gene Expression Omnibus",
            " and ",
            "Genotype-Tissue Expression",
            ", ",
            "Gene Ontology",
            " and pathway enrichment analysis to investigate the main functions of ACE2 -correlated genes."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 2145,
                "end": 2168,
                "name": "The Cancer Genome Atlas"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2170,
                "end": 2193,
                "name": "Gene Expression Omnibus"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 2198,
                "end": 2224,
                "name": "Genotype-Tissue Expression"
            },
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 2226,
                "end": 2239,
                "name": "Gene Ontology"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    }
]